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Chronic cerebral hypoperfusion is a characterized clinical situation which effects various 
neuropathological features such as small vessel disease. The widespread availability of 
magnetic resonance imaging has revealed extensive white matter abnormalities in man 
which are thought to be related to chronic cerebral hypoperfusion. 
 
Bilateral common carotid artery occlusion in the rodent is widely considered to model 
chronic cerebral hypoperfusion in man. In this thesis, we used bilateral common carotid 
occlusion in an attempt to answer the following questions.  
 
When are histology and functional imaging abnormalities evident after a long-lasting 
decrease in cerebral blood flow? What are the structures and cell types the most affected 
by the insult?  What is the temporal sequence of these changes?  
 
The aim of this thesis was, on the basis of our experimental results together with a critical 
reading of the available literature, to develop a credible and robust hypothesis to link 
chronic cerebral hypoperfusion to various neuropathological lesions. As with most 
scientific studies, the working hypothesis that was tested has given rise to even more 
questions.  
 





Vascular, especially cerebrovascular, dysfunction may be a critical factor in ageing and 
dementia. Cerebrovascular impairment due to risk factors such as ageing, stroke, 
smoking, diabetes and cerebral hypoperfusion has a deterious impact on the normal 
supply of basic nutrients such as oxygen and glucose to the brain; their absence leads 
inevitably to neuronal death. The cerebral white matter lesions found in most forms of 
dementia are reportedly the result of chronic cerebral hypoperfusion. However the 
temporal and spatial evolution of damage remains unclear. Furthermore, any decrease in 
the integrity of the blood-brain barrier (BBB) has been hypothesised to be a precocious 
attack on white matter. The “milieu interieure” the most protected in the body, namely 
the extracellular fluid of the brain, is no longer maintained homeostatically. The 
cumulation of these various pathophysiological processes alters cerebral function and it 
has been postulated that, in the most extreme instances, the outcome of this cascade of 
nefarious events leads to dementia. This thesis examines the supposition that chronic 
cerebral hypoperfusion could be responsible for the time-related development of white 
and grey matter pathology and investigates the relationships between the disturbances in 
the integrity of the BBB and white matter pathology. 
Three studies addressed these aims. In the first, chronic cerebral hypoperfusion, induced 
in male Wistar rats by bilateral common carotid artery occlusion (BCCAo), was chosen 
as the model to study changes in axons, myelin, perikarya as well as microglial 
activation. The groups of rats that underwent BCCAo were examined at three hours as 
well as three, seven, 14 and 28 days after the induction of chronic cerebral hypoperfusion. 
The microscopic examination revealed that, after three hours post BCCAo, damage was 
 xxi 
detected only in axons and myelin. In contrast, no visible pathology to the neuronal 
perikarya or enhancement of activated microglia (compared to the sham group) was 
observable. Injury in both white and grey matter and enhancement of activated microglia 
was observed from three days post BCCAo and increased with time post BCCAo. The 
most severe damage to the white and grey matter and enhancement of microglial 
activation was detected at seven days post BCCAo. These results would indicate that 
white matter damage precedes grey matter pathology and the enhancement of activated 
microglia.  
In the second study, the integrity of the BBB at three hours (when only white matter 
pathology was found according to the results of the first study) and seven days post 
BCCAo (when more severe damage to the white and grey matter was shown) was 
assessed by the use of MRI on T1-weighted image acquisitions with gadolinium as a 
tracer for BBB permeability. White matter integrity was measured by MTR maps from 
MTI acquisitions in four brain structures (corpus callosum, caudatoputamen, the external 
and internal capsules). No differences in white matter integrity were detected between the 
BCCAo and sham group at three hours and seven days. No differences in signal 
enhancement of gadolinium were detected three hours post BCCAo. However, a 
significant signal enhancement of gadolinium was detected at seven days post BCCAo in 
the caudatoputamen and in the external capsule. Furthermore, immunohistochemistry 
revealed a significant enhancement of activated microglia seven days post BCCAo 
compared to the sham group. This functional and immunohistochemical finding, when 
taken together, might indicate that chronic cerebral hypoperfusion is not in itself 
responsible for BBB permeability. Rather, the damage to the white matter caused by 
 xxii 
cerebral hypoperfusion may be responsible for the dysfunction of the BBB over time. 
Another point of interest was the evidence that the enhancement of activated microglia 
may play a critical role in the increased permeability of the BBB.  
The final study in this thesis aimed to investigate the possible pathway and proteins 
potentially implicated in white matter damage and BBB permeability. To address this 
question, protein levels and the expression of genes involved in the apoptotic and non-
apoptotic hypoxic pathways were compared to the sham groups (at three hours and seven 
days after BCCAo), in three brain structures (cortex, corpus callosum and 
caudatoputamen). The levels of HIF-1α, MMP-2, Caspase-3 and VEGF were unchanged 
compared to the sham group after BCCAo. However, VEGF mRNA expression was 
found to be significantly different to the sham group seven days post BCCAo in all the 
three structures examined. An overexpression of HIF-1α and a significant level of 
Caspase-3 would indicate the activation of the apoptotic pathway. However, neither of 
these criteria were met and these negative results suggest that the apoptotic pathway is 
not implicated in the mechanisms that lead to white matter pathology after cerebral 
hypoperfusion. Finally, the significant expression of VEGF mRNA, compared to the 
sham group seven days post BCCAo, may contribute to the time-relate increased 
permeability of the BBB. 
The results presented within this thesis provide a body of evidence to support the 
hypothesis that chronic cerebral hypoperfusion is - at least – causal to the damage to 
different components of the white matter which precedes either early ischaemic changes 
to the perikarya or enhancement of activated microglia following BCCAo. The increased 
permeability of the BBB, which can be related to the significant over-expression of 
 xxiii 
VEGF mRNA (compared to the sham group seven days post BCCAo), does not appear to 
be primarily responsible for white matter pathology, because the MRI investigations 
indicated that BBB integrity was not affected after three hours of BCCAo. The increased 
permeability of the BBB, observed seven days post BCCAo with MRI, seems to be the 
consequence of increased brain damage; thereafter, there is a time-dependent relationship 
between increasing BBB permeability and increasing brain pathology.  
Overall, the studies reported herein, strengthen the initial working hypothesis. The 
conclusion – and direction for future studies – would be that minimising white matter 
pathology and protecting components of the BBB represent potential targets to decrease 
then incidence of neuropsychological function or to obtund the cerebral dysfunction in 
patients who suffer from chronic cerebral hypoperfusion.           
 
 1 
CHAPTER 1: Introduction 
 
The brain, devoid of any meaningful reservoir of nutrients, is entirely dependent on the 
cerebral circulation, and a failure in perfusion may be implicated in the pathogenesis of 
many neurological disorders and psychiatric illnesses. Even normal ageing may be 
related to cerebrovascular disease (Choi et al., 1998) due to structural changes in the 
major arteries which lead to increasing stiffness and greater sensitivity to changes in 
systemic arterial pressure (Levy, 2001). These changes, as a function of age, have been 
observed in vivo by the use of magnetic resonance imaging (MRI); explicitly, MRI has 
identified ventricular dilatation and white matter hyperintensities as characteristic of 
ageing when compared to the younger brain (Raz, 2001). 
For many years, the importance of the white matter in the brain and its vulnerability to 
vascular changes has been neglected because of a focus on grey matter pathology. 
Specifically, the field of neurodegeneration caused by cerebral ischaemia and similar 
models concentrated on grey matter which might be one of the factors to explain the 
failure of pharmacotherapy in clinical trials. Importantly, some studies have demonstrated 
a considerable vulnerability of the white matter to ischaemia (Pantoni et al., 1996), and 
subsequent studies have shown that this vulnerability increases with age (Baltan et al., 
2008; Raz, 2001).   
Ischaemia, apoptosis, blood-brain barrier disturbances (Pantoni, 2002) and a long-lasting 
decrease in cerebral blood flow (CBF), now termed “chronic cerebral hypoperfusion” of 
the brain (Farkas et al., 2007), have all been hypothesised to be involved in 
cerebrovascular-related white matter lesions. Of interest, vascular pathology was also 
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observed in the original case of Alzheimer as “moderate atherosclerosis in the basal 
brain arteries of Auguste D” (Kalaria, 1999) and it is that age-dependent cerebrovascular 
dysfunction that increases the risk of Alzheimer’s disease (AD) (de la Torre, 2010).  
 
1. White matter 
 
The brain tissue is composed of grey and white matter. The grey matter contains the cells 
bodies (somata) of the neurons while the white matter consists of bundles of myelinated 
nerve fibres (axons) which convey the electrical signals between neurons. Both the 
somata and axons are in contact with glial cells (oligodendrocytes, astrocytes and 
microglia). All those components are in intimate contact with the cerebral blood vessels 
that supply the brain (Fig.1.1). Damage to any of these elements have functional 
consequences on the entire unit. 
1.1.1  Myelin 
 
The axons are of white appearance due to the myelin sheathing that contains about 80% 
lipids and 20% proteins. In the central nervous system (CNS), the oligodendrocytes 
fabricate the myelin as they do for peripheral nerves. Among the proteins present in the 
myelin sheath, the majority of them are specific for oligodendrocytes (Johnson et al., 
1989), for instance: the myelin associated glycoprotein (MAG); the myelin basic protein 
(MBP); myelin oligodendrocyte glycoprotein (MOG); and the proteolipid protein (PLP). 
MAG is a protein of 100 kilo Dalton (kDa). It is a transmembrane glycoprotein localised 




















MAG is involved in cell-surface recognition and it has been shown that the adhesion of 
oligodendrocytes to neurons is mediated by MAG (Poltorak, 1987). MAG is also 
implicated in promoting neuritic outgrowth during embryonic development but it inhibits 
axonal regeneration in the adult nervous system (Johnson et al., 1989; Mukhopadhyay et 
al., 1994). Buss and Schwab (2003) have shown that, following damage to nerve fibres, 
the peri-axonal myelin membrane proteins (e.g. MAG) are degraded more rapidly than 
those in compact myelin (e.g. MBP and PLP) or those in the outer myelin membrane (e.g. 
MOG). 
Myelination of the axons by the oligodendrocytes benefits the neurons in increasing the 
conduction velocity of the action potential and in decreasing the energy consumption by 
restricting ion currents and action potentials to less than 0.5% of the surface of the axon, 
while unmyelinated fibres need to consume a marked portion of ATP available for the re-
establishment of the ion gradient (Nave, 2010). 
    
1.1.2 Glial cells 
Glial cells are the majority of cells present in the nervous system. Rudolf Virchow 
described that cells other than neurons were present in the brain, naming them neuroglia 
(Virchow, 1846). Ramon y Cajal identified astrocytes among the neuroglia (Ramon y 
Cajal, 1913) and it was in 1921 that Rio Hortega found two other non-neuronal cells: 
oligodendrocytes and microglia (Rio Hortega, 1921).  
Glial cells are important for the normal function of the brain in general and in particular 
they are necessary for the correct development of neurons, for the function of mature 
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neurons by maintaining homeostasis, for producing the myelin and providing protection 
of, and support to, neurons. 
Oligodendrocytes are specialised in producing the myelin responsible for the more 
efficient propagation of the electrical signal as decribed above (Baumann et al., 2001). 
Microglia are the main mechanism for the active immune defense of the CNS, given that 
systemic antibodies cannot cross the blood-brain barrier (BBB). Microglia are smaller 
than oligodendrocytes and astrocytes but, after brain injury, they multiply rapidly around 
the lesion and migrate to the lesions site to initiate the immune response to the insult 
(Ransohoff and Perry, 2009). Ramified microglia (fig.1.2) react to pathological stimuli 
but do not have the morphology of macrophages (Kreutzberg, 1996; Stence et al., 2001; 
Petersen and Dailey, 2004; Davalos et al., 2005) because they fail to express the 
macrophage marker, CD 68 (Streit and Xue, 2012). Activated microglia express the CD 
68 antigen only after being engaged in phagocytic activity and can therefore be 
considered as macrophages (Graeber et al., 1998). 
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Fig.1.2: Iba-1 staining of microglia (brown) in the caudatoputamen of a rat control 
(from my own data) shows microglial cells (arrows) extending their processes 
around neurons, indicative of ongoing interactions between microglia and neurons. 












It is believed that, whatever the type of injury, microglia react in a stereotypic manner 
with a predetermined programme of executive functions. It has been shown that a 
phenotype (both inflammatory and cytotoxic) is acquired by microglia when activated in 
vitro by lipopolysaccharides (LPS) (Butovsky et al., 2005). Another interpretation might 
be that the microglial phenotype depends on the identity of the activating agent. 
Furthermore, the microglial responses are not inevitably neurotoxic.  
Various neuroprotective effects of microglial activation have been demonstrated in an in 
vivo model of stroke (Lalancette-Hébert et al., 2007) and AD (El Khoury et al., 1998). 
Among the neuroprotective functions of microglial cells are the production and secretion 
of neurotrophic factors: BDNF (Brain-Derived Neurotrophic Factor) (Elkabes et al., 
1996; Batchelor et al., 1999; Suzuki et al., 2001; Nakajima et al., 2002; Coull et al., 
2005); NGF (Nerve Growth Factor) (Mallat et al., 1989; Heese et al., 1997; Frade and 
Barde, 1998); TGF-ß (Transforming Growth Factor ß) (Kiefer et al., 1993; Lehrmann et 
al., 1998); bFGF (basic Fibroblast Growth Factor) (Araujo and Cotman, 1992); and 
GDNF (Glial cell-Derived Neurotrophic Factor) (Brudin, 2002; Batchelor et al., 1999; 
Suzuki et al., 2001). In AD, it has been shown that microglia increase in size and number 
in proportion to the size of amyloid plaques (Wegiel et al., 2001; 2003; 2004) and play a 
role in amyloid clearance from the brain (Lee and Landreth, 2010).  
Endogenous toxicity which might result from membrane breakdown products or 
aggregated proteins (e.g. beta-amyloid) lead to inflammation in the CNS, but if the 
concomitant microglial activation oversteps the threshold of tolerability, an exaggerated 
pathology rather than a defensive role might result (Schwartz et al., 2006). 
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To understand whether the CNS inflammatory response is protective or neurotoxic, it is 
essential to understand the control of the response (Carlson et al., 1998). 
Astrocytes are the most predominant glial cell type in the adult brain and are associated 
with synapses and cerebral blood vessels (Fig.1.1). They interact with the metabolic 
activity of neurons (Haydon and Carmignoto, 2006) by regulating the concentrations of 
ions and recycling neurotransmitters released during synaptic transmission (Verkhratsky 
and Steinhäuser, 2000). As well as this role, astrocytes are in contact with neurons, 
oligodendrocytes, microglia and cerebral blood vessels; this multiplicity of anatomical 
relationships underlies the importance of the presence and homeostatic function of those 
glial cells, given that processes from a single astrocyte can envelop about 140,000 
synapses (Bushong et al., 2002). Another important role of astrocytes is the coupling of 
CBF to neural activity. Indeed, Takano and collaborators (2006) have shown that 
electrical stimulation of cortical neural activity induced important Ca2+ increases in 
astrocytic endfeet, resulting in vasodilatation of cerebral blood vessel which, in turn, 
leads to an increase of CBF. 
All those white matter components are interconnected, with an essential communication 
between all of them that is a function of the basic nutrients needed for normal function 
and supplied by the blood vessel: glucose and oxygen.  
Cerebral blood vessels are highly specific and differ from those in the rest of the body by 





1.2 The Blood-Brain Barrier 
The brain is protected by many lines of defense. First, and one of the most important: the 
hepatic system, responsible of the metabolism, combination and detoxification of the 
large majority of harmful exogenous and endogenous molecules. A second line of 
defense includes all the interoceptor systems that are essential for maintaining the 
homeostasis of the internal milieu of the brain. Examples are: the chemoreceptors (for 
pO2, pCO2 and pH) that transduce a chemical signal into an action potential; the 
baroceptors that maintain a constant arterial pressure to the brain; the central 
osmoreceptors and thermoreceptors…The third line of defense of the brain is the blood-
brain barrier (BBB).   
In the brain, as in most organs and tissues, the capillary is that segment of the vasculature 
in which exchange occurs between blood and the extracellular fluids. The brain is, 
accordingly, protected from abnormal changes of its ionic composition which occur after 
exercise or a meal which – without the BBB – could disturb synaptic and axonal 
communication (Cserr and Bundgaard, 1984). 
It is also important to underline the fact that some regions in the brain, the 
circumventricular organs, do not have a BBB: the area postrema, the median eminence, 
the neurohypophysis, the pineal gland, the subfornical organ, and the lamina terminalis 
(Ballabh et al., 2004). Blood vessels in those areas possess fenestrations that allow the 
diffusion of molecules (e.g. hormones) through their walls. Those brain areas without the 
BBB regulate certain effects of the autonomic nervous system and endocrine glands of 




In 1885, the German bacteriologist, Paul Ehrlich, noted that - following intravenous 
injections of aniline dyes - all of the organs would be stained except the brain. He made 
then the hypothesis of a difference of affinity of fixation of the dye between the CNS and 
the rest of the body. 
In 1898, Bield and Kraus, as well as Lewandosky in 1900, described direct effects on the 
brain following intracerebroventricular injection of cholic acid and ferrocyanide, whereas 
no effects were noted after intravenous injection. Then, they postulated a presence of a 
vascular barrier, introducing the name of BBB to describe this phenomen. 
In 1909, Edwin Goldman reproduced Ehrlich’s experiment using trypan blue, 
demonstrating that only the CNS was stained after an injection below the arachnoid, 
which demonstrated the presence of a barrier between the cerebral parenchyma and the 
vascular compartment. 
The hypothesis mentioning that the cerebral capillaries are the anatomic basis of the 
barrier was only confirmed in the late 1960s following the introduction of the scanning 










The BBB is composed of endothelial cells joined by both tight (occludens) and adherens 
junctions, the capillary basement membrane, astrocyte end-feet ensheating the vessels 
and pericytes embedded within the basement membrane (Fig.1.3).  
Electron microscopy demonstrated that the BBB is an endothelial barrier which is present 
in the cerebral capillaries and absent in the circumventricular organs. 
Indeed, a functional neuropil depends on an intact endothelial BBB, which differs from 
the peripheral endothelial cells by morphological and functional characteristics: 
 Abundance of mitochondria (8-11% of the cytoplasmic volume)  
 Presence of tight junctions (most evident close to the luminal surface) 
 Sparse pinocytotic intracellular vesicles (under normal conditions) 
















               
Fig.1.3: A Diagrammatic cross-section of a cerebral capillary to illustrates the 





















1.2.2.1 Interendothelial cells junction 
 
1.2.2.1.1 Tight junctions 
The tight junctions (zonluae occludentes) establish a selective barrier in the paracellular 
space between the endothelial cells and so form a structural and functional syncytium 
throughout the cerebrovascular system. One of the most obvious physiological roles of 
this syncitium is to limit the passage of both water and ions between blood and the 
extracellular fluids of the CNS. Tight junctions are, however, higly dynamic entities 
whose degree of sealing varies as a function of external stimuli as well as being modified 
according to differing physiological and pathological conditions (González-Mariscal et 
al., 2008; Deli et al., 2009). 
The tight junctions were so named, following electron microscopic studies which 
incrorrectly supposed that they are static and impenetrable: in reality; they are highly 
dynamic structures which, for example, allow the migration of leukocytes into the brain, 
without any disruption of the BBB (Van Itallie et al., 2004). Another role for the tight 
junctions has been proposed in which they act as dynamic signalling complexes involved 
in the control of gene expression, cell proliferation and differentiation (González-
Mariscal et al., 2008). 
Electronic microscopy shows that the tight junctions appear as a series of discrete 
contacts between the plasma membranes of adjacent cells.  By freeze-fracture electronic 
microscopy, tight junctions appear as proteins closely associated to each other as a series 






















Fig.1.4: BBB and the tight junction. A: Schematic illustration of the tight junctions 
(Ballabh et al., 2004). B: Electronic microscopies of the endothelial cells link each other 
with the tight junctions (arrows) and adherens junctions (za). (m: microtubules; ac: actin 







Three group of protein can be distinguished (fig. 1.4): 
 Transmembrane proteins: claudins, occludin and JAMs (junctional adhesion 
molecules) 
 Cytoplasmic accessory proteins: cingulin, zonula occludens 1, 2 and 3 (ZO-1, ZO-
2 and ZO-3) (Hawkins et al., 2005) 
 Cytoskeleton protein: actin 
The transmembrane proteins are connected to the actin cytoskeleton by the tight junction 
accessory proteins: ZO-1, ZO-2, ZO-3. 
The JAMs are involved in the formation and in the maintenance of the structure of the 
tight junctions (Vorbrodt and Dobrogowska, 2003; Abbott et al., 2006) and are involved 
in the regulation of the transendothelial migration of leukocytes (Del Maschio et al., 
1999). 
 
1.2.2.1.2 Adherens junctions 
These junctions include the membrane protein, cadherin that joins the actin cytoskeleton 
via intermediary proteins, called the catenins, to form adhesive contacts between 
endothelial cells. Adherens junctions are calcium-dependent and essential for the 
formation of the tight junctions. A disruption of the adherens junction by the removal of 
extracellular calcium leads to a disruption of the tight junctions (Hirase et al., 1997), 






Pericyte processes are present around cerebral capillaries, covering 22 to 32% of the 
capillaries (Cardoso et al., 2010) which they are invested by a duplication of the 
basement membrane to which they are directly apposed. Although the exact function of 
pericytes is unknown, some studies highlight their important role in the brain vasculature. 
Peppiatt et al. (2006) demonstrated that pericytes play a role in constricting the vessel 
wall. By stimulating electrically the somata of retinal pericytes, a capillary constriction 
was noted, consequent to an increase in intracellular [Ca2+]. Moreover, pericytic 
degeneration in adult and ageing brain leads to a loss of integrity of the BBB prior to the 
phenomena of neurodegeneration or cerebral inflammation (Bell et al., 2010). 
 
1.2.2.3 Astrocytes 
Astrocytic end-feet are structurally the closest element to the endothelial cells of the brain 
capillaries, with the exception of the pericytes, by covering a large surface of the BBB 
endothelium and its associated basement membrane (fig.1.5). 
A number of cell culture studies have suggested that the ability of CNS endothelial cells 
to establish a BBB is not specific to these cells; rather, it is the micro-environment to 
these cells that confers the barrier properties to brain capillaries. Indeed, cultured 
astrocytes, implanted into areas with normal leaky vessels, induced the formation of 
endothelial cells endowed with tight junctions (Janzer and Raff, 1987) and this by a 




Astrocytes are also integral to normal neuronal function and the close proximity of 
neuronal cell bodies to brain capillaries indicates that interactions among all those 
components are essential for the proper function of each of the components (Persidsky et 
al., 2006); a disturbance in one of them may induce changes in the functionality of the 
BBB. 
 
                                                             




1.2.3 Functions and properties of the BBB 
The BBB exhibits specific functions and properties essential for the protection of the 
brain from peripheral changes. 
The BBB is a selective barrier where lipid-soluble and small gaseous molecules such as 
O2 and CO2 can diffuse passively through the BBB. In contrast, the passage of most ions 
and protons as well as large molecules between the blood and the brain are restricted 
(Pardridge, 2003; Abbott et al., 2006). However, specific transport systems present on the 
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membrane surfaces of the endothelial cells allow the entry of essential nutrients including 
amino-acids and excludes any potentially harmful compounds (Begley and Brightman, 
2003).   
 
1.2.4 BBB permeability 
Several mechanisms can modify BBB permeability: these adaptations include the 
separation of the interendothelial tight junctions, an increase of vesicular transport and 
the formation of transendothelial channels, or the biochemical and structural alterations 
of the endothelial membrane resulting in an increase in its permeability. 
The opening of the tight junctions has not been observed in experimental simulations of 
conditions that lead to an increased BBB permeability. However, an increase in 
pinocytotic activity has been observed following intravenous injection of mercury or 
nickel salts in the rat (Joó, 1971). Godeau and Robert (1979) also observed a significant 
increase in the number of pinocytotic vesicles after the intravenous injection of 
collagenase or pronase to rats. Burns and collaborators (1981) noted a significant increase 
in the density of pinocytotic vesicles after the intravenous injection of clinically used 
contrast agents. 
Those changes (i.e increased pinocytotic activity), occur after various pathological 
stimuli and are usually transient. Formation of open channels across the capillary 
endothelium has not been observed (Povlishock and Kontos, 1982; Balin et al., 1987). 
Other studies have suggested that, following brain damage, there may be a disturbation of 
the endothelial plasmalemma (Kawai et al., 1989; Maxwell et al., 1988). 
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Many studies have shown a disruption of the BBB after cerebral ischaemia/reperfusion. 
However, it is not the decrease of blood flow supply that leads to BBB permeability but, 
rather, the reperfusion of the brain with an elevated arterial pressure into already dilated 
cerebral vessels, dilated as the joint result of acidosis and an absence of autoregualtion, 
both induced ischaemia. The study of Yang and Betz (1994) clearly demonstrates this 
sequence of events. By comparing one group which was subjected to six hours of 
permanent middle cerebral artery occlusion (MCAo) to a group with three hours of 
occlusion followed by three hours of reperfusion, they found no increase of permeability 
of the BBB to the tracer used in the group of permanent MCAo, while the group which 
was subjected to 3 hours of reperfusion exhibited a disruption of the BBB.  
It has been well established that two independent factors increase the permeability of the 
BBB (Kuroiwa et al., 1985). The first to increase the permeability of the BBB, the 
haemodynamic response, occurs just after recirculation in vasodilated vessels, whereas 
the second increase in BBB permeability is induced by unknown agents released from the 
damaged tissue, at a time when endothelial cells and tight junctions seems to be well 
preserved (Westergaard et al. 1976). This scenario explains the fact that, in several 
diseases that affect the CNS, an increase in permeability of the BBB is seen as a 
consequence of the pathology. This was the predominate view that prevailed to explain 
the sequence of events in models such as in cerebral ischaemia (Valable et al., 2005) or in 
traumatic brain injury (Readnower et al., 2010). A second view emerged seeing the 
increase of permeability of the BBB as being the cause – and not consequence - of brain 
damage in white matter diseases such as multiple sclerosis. Indeed, BBB permeability 
may be one of the initial events leading to the disease (De Keyser et al., 2008).  
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In ageing, an increase in permeability has been detected and it may be one of the leading 
causes of cerebral microvascular disease (Farrall and Wardlaw, 2009). Various 
histological changes in brain vasculature are described such as loss of capillary 
endothelial cells, a decreased capillary diameter in the rat cortex, a decrease in the 
number of mitochondria in endothelial cells in the monkey. Alterations in BBB transport 
have also been observed such as that of choline and a decrease in glucose influx to the 
brain (Kleine et al., 1993; Tang and Melethil, 1995; Mooradian et al., 1988). Wardlaw 
and collaborators hypothesized that, after an alteration in endothelial function, BBB 
disruption may be involved in the pathogenesis of lacunar stroke and the integrity of the 
BBB decreases with normal ageing (Wardlaw, 2008 and 2010). 
As a function of the intensity and duration of hypoperfusion, damage to the brain can be 
the cause or the consequence of an increase in BBB permeability. To illustrate this point, 
Kuroiwa et al. (1985) demonstrated that a significant decrease of CBF (below 
15ml/100g/min.) caused by transient cerebral ischaemia, and followed by an important 
hyperaemia lead to a disruption of the BBB, while a moderate decrease of CBF (above 
15ml/100g/min.) fails to “open” the BBB. 
Marked changes in CBF do not instantaneously lead to an increase in BBB permeability. 
Some authors (Tomimoto et al., 1996; Ueno et al., 2002) have hypothesized that a 
chronic decrease in the blood supply to the brain, such as hypoperfusion, may be 
responsible of the damage to the white matter, through a progressive breakdown of the 
BBB, and this cascade of events favourises cognitive impairments such as seen in 
Alzheimer’s, leukoaraiosis or vascular dementia.      
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1.3 Chronic cerebral hypoperfusion 
Local brain activity determines cerebral oxygen and glucose consumption as well as 
blood supply to the region specifically activated. These highly focalized relationships 
take place in the context of an unchanged global perfusion of the brain: the phenomenom 
of cerebral autoregulation. 
 
1.3.1 Cerebrovascular autoregulation 
The brain is dependent on a continuous supply of blood. CBF is qualified by cerebral 
perfusion pressure (CPP), which is defined as the difference between mean arterial 
pressure and intracranial pressure, and cerebrovascular resistance (CVR) (CPP divided by 
the CBF defines the CVR).  The CPP, which, in most situations is identical to mean 
arterial pressure, is the net pressure driving blood flow to the brain. 
Within physiological limits, any changes in CPP feedback negatively to change CVR, 
maintaining then a relatively constant CBF. If the CPP decreases, the CBF does not fall, 
because of the automatic compensatory decreases in CVR. Likewise, an increase in CPP 
does not produce an increase in CBF because of automatic compensatory increases in 
CVR (Aaslid et al, 1989). Beyond those limits in which this autoregulation of CBF 
operates: CPP range of 50 to 170mmHg (Harper, 1966; Berne et al., 1981), CBF will fall 
or rise as a function of CPP. 
Furthermore, when the capacity for autoregulatory vasodilatation to maintain blood flow 
near normal limits is near exhausted, while arterioles continue to dilate, CBF falls with 
CPP but the oxygen extraction fraction (OEF) increases to maintain normal CMRO2. The 
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brain enters then in a most severe stage of haemodynamic impairment called “misery 
perfusion” (Baron et al., 1981), also termed oligaemia or cerebral hypoperfusion. 
An abrupt disruption of the blood supply to brain regions leads to stroke and whatever the 
type of stroke, there is an imbalance between blood supply and metabolism of the CNS, 
with, as consequence, severe neuronal damage located in the affected territory or 
territories. While a chronic but moderate decrease in regional CBF is not associated with 
a necrotic infarction it does affect memory processes (Sopala and Danysz, 2001; Tanaka 
et al., 1998; De Jong et al., 1999) and can be involved in the development of dementia 
(Farkas et al., 2007).  
Chronic cerebral hypoperfusion has been identified in ageing, AD and other forms of 
dementias (Buée et al., 1997; Farkas and Luiten, 2001). Finally, it has been hypothesized 
that chronic cerebral hypoperfusion is the cause of the onset of AD (de la Torre, 2004). 
 
1.3.2 The effects of chronic cerebral hypoperfusion on white (versus grey) matter 
integrity 
The pathogenesis of white matter changes in the brains of subjects with AD has been 
attributed to chronic cerebral hypoperfusion and it has been shown that white matter is 
more susceptible to damage with chronic cerebral hypoperfusion than grey matter (Brun 
and Englund, 1986). However, in AD and other neurodegenerative processes, it has never 
been demonstrated that those lesions are unique to white matter, as atrophy of both grey 
and white matter has been observed (De la Monte, 1989). Moreover, this global cerebral 
hypoperfusion which occurs (Carmeliet et al., 1988) leads to a decrease in flow through 
the cerebral capillaries and hence will decrease the avaibility of nutrients for the brain, 
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culminating then in neuropathological features close to those of AD (Cho et al., 2006). 
The neuropathological changes in such cerebrovascular lesions are characterized by 
demyelination and axonal loss. During normal ageing, post-mortem studies have shown a 
breakdown in the structural integrity of myelin sheaths (Bartzokis et al., 2003) similar to 
the histopathological picture found in patients with AD (Terry et al., 1964). Discrete 
vascular changes have been noted in normal ageing and AD that include alterations in 
endothelial function (Levy, 2001) and a thickening of the basement membrane of the 
vessels (Buée et al., 1997) (fig.1.6). Any changes in vascular diameter lead to direct 
alterations in CVR and CBF (Farkas and Luiten, 2001). Moreover, in small vessel 
diseases (SVD), the microvascular degeneration is attributed to be the cause of white 
matter lesions in elderly people (Takebayashi and Kaneko, 1983). Vascular risk factor 
such as ageing, hypertension, diabetes, hypercholesterolemia, ischaemic heart diseases 
and smoking may be causal factors in the development of cerebral hypoperfusion of the 
brain which may lead to AD and white matter lesions (O'Brien et al., 2003). White matter 
hyperintensities - the radiological equivalent of demyelination - correspond to lower CBF 
in MRI (Mastrand et al., 2002) and in positron emission tomography (Turc et al., 1994). 
Following focal cerebral ischaemia in the rat model, it has been shown that white matter 
structures were sensitive to a decrease in CBF (Pantoni et al., 1996). Moreover, some 
studies indicate that this sensitivity increases with age (Baltan et al., 2008). In contrast, 
Falcao and collaborators (2004) stated “the resistance to ischemia of white and gray 
matter after stroke”, but their data presented, in patients after acute ischaemic stroke, 
indicated that both white and grey matter showed hypoxic injury on MRI but “a 
potentially salvageable tissue in human white matter” was observed, and this refers to the 
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penumbra which corresponds to the hypoxic tissue that can be saved through therapeutic 
treatment in a therapeutic window of 3 hours (The National Institute of Neurological 
Disorders and Stroke rt-PA Stroke Study Group, 1995). “Thus, the limited 3 h therapeutic 
window only benefits 3% to 8.5% of all stroke admissions in individual centers” (Zhan et 
al., 2011). 
Some studies have lent support to the hypothesis that leukoaraiosis (rarefaction of the 
white matter detected in MRI (fig.1.7)) may be the result of an altered cerebrovascular 
autoregulation (Pantoni and Garcia, 1997). Histopathological studies in differing animal 
models provide evidence of damage to the white matter structures after a long-term 
















Fig.1.6: A thickening of the basement membrane is observed in ageing. In AD, this 
thickening is more important with the addition of vacuolisations within the basement 












Fig.1.7: MRI showing enlarged ventricles (green arrows) and white matter 
hyperintensities (red arrows) in a 79-year-old man (right) which correspond to white 
matter rarefaction. On the left, a 24-year old male (normal). (Modified from Raz, 2001) 
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1.3.3 Animal models of chronic cerebral hypoperfusion 
Various models have been advanced to study the effect of hypoperfusion on the brain. 
Stroke models have been used to investigate the short-term effects of vascular occlusion. 
Focal disruption of the blood supply to specific regions leads to an infarction, or 
pannecrosis, and neurological signs and signs and symptoms appropriate to the territory 
irrigated. Pannecrosis is the total loss of all cell elements (neurons, glia, vascular cells…) 
in the zone afflicted by the focal ischaemia. Two models of focal cerebral ischaemia have 
been proposed: a permanent (Tamura et al., 1981) and a transient (Longa et al., 1989) 
MCAo. In the commonly used model of transient MCAo, reperfusion is effected which 
engenders a damage more severe than that seen in the permanent MCAo model. The focal 
ischaemic lesion can be divided into a necrotic core and a region of penumbrae (Astrup et 
al., 1981). However, the severity of the ischaemic insult reduces considerably the 
opportunity to have a reserve of potentially salvageable penumbral tissue for rescue in 
man (Macrae, 2011). Hence, the interest for a novel model based on a moderate and 
chronic decrease in CBF. 
In apposition to stroke experiments, the chronic cerebral hypoperfusion model aims to 
investigate an extended period of global CBF hypoperfusion without reperfusion where 
there is no ischaemic core and penumbral region, and the neuropathological outcome is 
less severe than that seen in “stroke” models (Farkas et al., 2007). In conclusion, chronic 
cerebral hypoperfusion, induced by a decrease in diameter of the conducting arteries, 
provokes clear white matter pathology without the necrotic infarction associated with 
stroke. 
 27 
In the elderly, microvascular degeneration (SVD) (as discussed below) seems to provoke 
white matter lesions (Takebayashi and Kaneko, 1983) and vascular pathology was also 
observed in the white matter alterations in the original case of Alzheimer as “moderate 
atherosclerosis in the basal brain arteries of Auguste D” (Kalaria, 1999). Ueno and 
collaborators (2002) detected changes in the microvascular ultrastruture of the rat brain 
after chronic cerebral hypoperfusion which equally led to BBB damage. These 
characteristics indicate that, in reality, the induction of chronic cerebral hypoperfusion 
modelizes SVD. Four types of structural changes have been described in small vessel 
diseases affecting vessels of different size ranges:  
 Atherosclerosis affecting distal vessels of diameter: 200-800 µm (Ferrer et al., 
2008) 
 Lipohyalinosis (also referred as complex SVD) describes fibrinoid deposition in 
the vessels walls of diameter: 40-300 µm (Fisher, 1972) 
 Arteriolosclerosis with hyaline thickening in arterioles of 50-150 µm diameter 
(Lammie, 2000) 
 Microaneurysms that occurs at branching sites in vessels of 100-300 µm diameter 
(Spangler et al., 1994) 
It would appear from our analysis of the literature that the model of bilateral common 
carotid artery occlusion (BCCAo) replicates a state of atherosclerosis following a chronic 
decrease of CBF, with the proviso that both common carotid arteries are completely and 
permanently occluded. 
Rodents have been commonly used as models for chronic cerebral hypoperfusion due to 
their economic and ethical acceptability (Ginsberg and Busto, 1989). Damage that occurs 
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in those hypoperfusion models is not exclusive to the white matter. In rodents, the 
white/grey matter ratio is much lower than in human (Hagberg et al., 2002).  
In the gerbil model, microcoils have been introduced around both common carotid 
arteries without totally occluding the vessels. The microcoils are often placed in one 
carotid while a second is set after a certain time delay, because of the sensitivity of the 
gerbil to anaesthesia and surgery (Kudo et al., 1990; Hattori et al., 1992). These 
microcoils decrease the blood supply to the brain by producing a stenosis (fig.1.8a&b). 
This procedure induces a reduction of the CBF to less than 75% of the baseline levels in 
the gerbil. Hattori et al. (1992) noted that majority of the gerbils showed unilateral lesions 
was explained by the fact that the gerbil has an incomplete circle of Willis. One week 
after common carotid arterial stenosis, neuronal loss, dark neurons and neuronal 
degeneration were observed in selected grey matter regions.  








Fig.1.8: Models of chronic cerebral hypoperfusion in rodents. A: microcoil placed on the 
common carotid artery of the mouse (Shibata et al., 2004) which produces a stenosis of 
the vessel (Farkas and Luiten, 2001) (B). C: Bilateral common carotid artery occlusion in 








In the mouse model (see fig.1.8a), the procedure developed recently by Shibata et al. 
(2004) is identical to that in gerbil and leads, for instance, to a decrease in CBF to 70% of 
control after 2 hours (with a coil diameter of 0.18mm) and recovery after 30 days to 90% 
of baseline values (fig.1.9). Shibata and collaborators (2004) found that the damage was 
specific for white matter, being more intense in the corpus callosum and less severe in the 
optic tract, when microcoils of 0.18 and 0.20 mm were used; there was a total absence of 




Fig.1.9: CBF decrease in the mouse after bilateral common carotid artery stenosis of 
varying severity (obtained by the placement of microcoils of graded diameter and as a 






A controversial result is that of Shibata et al. (2004) who found that the C57Black/6 
strain of mouse exhibits a higher sensitivity to injury after chronic cerebral hypoperfusion 
or middle cerebral artery occlusion due to a poorly developed posterior communicating 
artery (Fujii et al., 1997; Kim et al., 2009). 
In the rat model, the male Wistar rat presents a complete circle of Willis and the 
occlusion of both common carotid arteries engenders to a situation of cerebral 
hypoperfusion rather than ischaemia due to the compensatory flow from the 
vertebrobasilar system. 
The male Wistar rat model (fig.1.8c) is commonly used to induce a chronic cerebral 
hypoperfusion, leading to a decrease of the regional CBF (rCBF) of 33 to 45% of the 
control level in the white matter and cortical areas after two days of BCCAo (Otori et al., 
2003). rCBF begins to recover to 81.3 to 92.5% of baseline values after eight weeks of 
BCCAo (fig.1.10). 
 
Fig.1.10: Regional CBF decrease in the rat after permanent bilateral common carotid 
artery occlusion and as a function of time following the induction of hypoperfusion (Otori 
et al., 2003). 
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1.3.4 The effects of BCCAo on neuropsychological indices 
A number of studies have demonstrated that chronic cerebral hypoperfusion is one of the 
primary causes that contributes to memory impairment and vascular dementia (Farkas 
and Luiten, 2001; de la Torre, 1994; de la Torre, 2000). Most of the tests used to measure 
spatial learning memory after BCCAo in the rat have been based on the Morris water 
maze and the eight-arm radial maze (Ni et al., 1994; Farkas and Luiten, 2001; Farkas et 
al., 2004; Liu et al., 2005; Shang et al., 2005). Seven days after BCCAo, spatial memory 
was already significantly impaired in the BCCAo rats (de la Torre et al., 1997; Pappas et 
al., 1996) and learning and memory performances were significantly impaired with time 
compared to the sham-operated rats (Liu et al., 2005; Ni et al., 1994; Pappas et al., 1996). 
Those results indicate that chronic cerebral hypoperfusion leads to progressive cognitive 
impairement. 
 
1.3.5 The effects of BCCAo on neurons and glial cells 
In BCCAo rats, no damage to the neurons of the CA1 could be detected during the first 
week of BCCAo as evaluated by Haematoxylin and Eosin (H&E) staining (Ohtaki et al., 
2006). However, another group who studied the effects of BCCAo in the rat from one 
hour to eight weeks post BCCAo found ischaemic neuronal damage two weeks after 
BCCAo (Schmidt-Kastner, 2001) while Bennett et al. (1998) detected necrotic pyramidial 
cells two weeks following BCCAo. Thirteen weeks post BCCAo, Sarti et al. (2002) failed 
to detect any neuronal damage in any grey matter structure examined. This latter study 
can be explained by the fact that macrophages may have removed any neuronal damage 
by this time and, hence, a false negative finding. Controversely, Farkas and collaborators 
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(2004) found total unilateral hippocampal lesions in four of six BCCAo rats, thirteen 
weeks post BCCAo. It has been proven that necrotic cell death occurrs before eight 
weeks of BCCAo due to low levels of ATP; by eight weeks post BCCAo, ATP levels 
returns to the control level (Briede and Duburs, 2007; Plaschke, 2005) which concord 
with the fact that necrosis is characterised by a lack of energetic substrate (Ueda and 
Fujita, 2004). Wakita and collaborators (1994) have investigated astrocytic reactions and 
microglial activation after BCCAo from 1h to 90 days and found that both parameters 
were significantly different but only after seven days post BCCAo. Others detected overt 
microglial activation after fourteen days post BCCAo (Farkas et al., 2007). Astriogliosis 
and microglial activation continue to increase at thirteen weeks post BCCAo (Farkas et 
al., 2004; 2005) 
 
1.3.6 The effects of BCCAo on white matter integrity 
White matter injury has been described in several studies which have identified the optic 
tract as being the more vulnerable white matter region in the rat brain due to its direct 
blood supply from the internal carotid artery (Takizawa et al., 2003, Wakita et al., 2002; 
Farkas et al., 2004, Ohta et al., 1997). Most of the studies have used the Kluver-Barrera 
staining to detect vacuolisations and rarefaction of the white matter from two days to four 
months post BCCAo; electron microscopy has shown that myelin sheaths were damaged, 
with an increase of oligodendrocyte density (Farkas et al., 2004; 2005; Wakita et al., 
2002; Otori et al., 2003; Lee et al., 2006; Wakita et al., 2003; Ohta et al., 1997; Wakita et 
al., 1994; Cho et al., 2006).  
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Demyelination, axonal damage (Wakita et al., 2002), astrocytic proliferation, microglial 
activation, apoptic cell death of oligodenrocytes and astrocytes (Lee et al., 2006) and 
increased percentage of vacuoles in white matter tract (Tazikawa et al., 2003) indicate the 
pathological hallmarks in the white matter with time after BCCAo similar to those 
identified in post mortem human white matter lesions (Sheltens et al., 1995; Tomimoto et 
al., 1997; Kobayashi et al., 2002). 
 
1.4 Objectives and aims of this thesis: 
As stated in the introduction, chronic cerebral hypoperfusion could be at the origin of 
several pathological modifications in the brain and, hence, their dysfunctional and 
neurological corollaries. The field is vast but we have focused on three specific questions, 
detailed below. 
 
1. Characterising the effects of BCCAo on white and grey matter as well as 
microglial activation at early and later time end-points following BCCAo. 
To understand the possible pathway of pathophysiology after BCCAo, a detailed 
examination of axons, myelin, microglial activation and neuronal somata was undertaken 
at time points ranging from 3 hours to 28 days following BCCAo. 
Numerous studies have shown the susceptibility of white matter to chronic cerebral 
hypoperfusion as manifested by: a rarefaction of both axonal and myelin components 
(Wakita et al., 2002; Kim et al., 2008; Cho et al., 2006; Takizawa et al., 2003); loss of 
oligodendrocytes (Taupin et al., 1997); gliosis (Wakita et al., 1994; Ritchie et al., 2004); 
and microglial activation (Farkas et al., 2004). However, none has compared temporal 
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sequences of each of these pathological processes and their underlying causes. White 
matter pathology, in the chronic cerebral hypoperfusion model, has become the object of 
attention but the link between white and grey matter pathology has been little detailed. It 
still remains unclear whether white matter damage occurs before, with, or after grey 
matter damage in the rat hypoperfusion model. Secondly the question remains as to 
whether enhancement of activated microglia matches white and/or grey matter damage 
with time, again in the same model. 
 
2. Is an increase of BBB permeability responsible for the pathology of the white 
matter? 
It was hypothesised that chronic cerebral hypoperfusion is a causal factor with respect to 
BBB damage. With the knowledge that no unequivocal evidence has been presented for 
the increased permeability of the BBB after BCCAo; it is therefore important and 
legitimate to know if the increase of permeability of the BBB is instrumental in the 
pathology of the white matter.  
 
3. Which proteins could be implicated in the pathology of the white matter? 
It has been postulated that chronic cerebral hypoperfusion provokes neuronal death and 
energy failure as a consequence of decreased blood flow and hypoxia. The final question 
that we have investigated in this thesis: is the degree of hypoxia sufficiently low to 
activate the pathway(s) of apoptosis and which pathway(s) could explain the differences 
between the pathological changes in grey and white matter in a model of chronic cerebral 
hypoperfusion? 
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All animal procedures were carried out under a UK Home Office project and personal 
licence and adhered to the regulations specified in the Animals (Scientific Procedure) Act 
(1986).  
 
2.1.1 Bilateral common carotid arteries occlusion (BCCAo) 
Adult male Wistar rats (280-320g, Charles River laboratories - UK) were deeply 
anaesthetized in an induction box with 5% isoflurane in 30% oxygen/70% nitrous oxide, 
intubated and mechanically ventilated with 2-2.5% isoflurane in 30% oxygen/70% 
nitrous oxide for the duration of the surgery. Via a small incision in the neck, both 
common carotid arteries were exposed, separated from the vagi and double ligated with a 
silk suture (see fig.1.8c) as described previously (Wakita et al., 1994). The control (sham) 
rats underwent the procedure without occlusion of the common carotid arteries. Rectal 
temperature was measured via a thermometer probes and controlled during surgery. Then 
the rats recovered from anaesthesia and food and water were provided ad libitum in their 
own cages and were monitored. At specific time points after the beginning eof chronic 
cerebral hypoperfusion, animals were perfused transcardially with 0.9% saline and 4% 
paraformaldehyde (PFA). Rat brains were then removed and processed for paraffin 
embedding and 6µm sections cut for histology and immunohistochemistry. 
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2.1.1.1 CBF measurements in the BCCAo model 
We did not measure CBF after ligation of both common carotid arteries due to the 
number of concordant studies which have clearly described the pattern of CBF after the 
induction of BCCAo in the rat (see table 2.1). Immediately after the BCCAo procedure, 
the rCBF decreases to 34% of the control in the cortex, 58% of the control in the 
hippocampus, 70% of the control in the thalamus (Choy et al., 2006) and 48% of the 
control in the left temporal window (Watanabe et al., 2006). The greatest decrease in 
rCBF was recorded in the cortical and white matter areas immedialtely after BCCAo until 
1 week after BCCAo, thereafter rCBF started to recover, but still significantly lower than 
the baseline. In the cortex rCBF values were 40 to 63% of the control and in the white 
matter rCBF was 42 to 72% of the control (Otori et al., 2003; Schmidt-Kastner et al., 
2001; Tomimoto et al., 2003; Tsuchiya et al., 1992). After 4 weeks of BCCAo, the rCBF 
is still significantly lesser than control and from 2 to 6 months after BCCAo, either a 
slight decrease of rCBF or no change were recorded (Otori et al., 2003; Ohta et al., 1997; 
Choy et al., 2006).  
These data explicitly indicate that a permanent ligation of both common carotid arteries 
leads to an immediately decrease in CBF which slowly recovers with time after a period 
of approximately 8 weeks post BCCAo.  
The cortical CBF values, from the eleven available studies in the literature, are plotted as 
a function of time (minutes following BCCAo), the half-maximal recovery is achieved 
seven days after the intervention. The theoretical maximal decrease in CBF is – 80% 
from control values and – as stated above – full recovery is obtained 2-6 months after 
BCCAo. The various values for the CBF decrease immediately after the ligation of the 
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carotid arteries are somewhat scattered but this variation might be inherent to the time 
constant of the different methods employed to estimate CBF (fig. 2.1). From 24 hours and 
later after BCCAo, the numerous studies are highly concordant. Given the richness and 
coherence of the published cerebrovascular effects of BCCAo, the originality and ethical 
justification of future investigations could be questioned.  
 
 
Fig.2.1: CBF (decrease from baseline or control values) as a function of log.time (in 
minutes) following BCCAo from the studies published in the literature as shown in table 
2.1). The present investigations were performed between three and 28 days at which 
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2.1.1.2 Principle determinants of BCCAo outcome 
The outcome after bilateral common carotid ligation in rodents is dependent upon 
cerebral vascular anatomy, arterial pressure, age and anaesthetic agents. No coherent 
view of the relative importance of these factors emerges from a comprehensive review 
from the literature (see Table 2.2). The response (i.e. mortality and morbidity) to the 
procedure cannot be predicted from published work because of the disparity of results 
found in a model of chronic cerebral hypoperfusion as regards the rate of mortality, the 
severity of damage, the various anaesthetic agents used, the strain of rodent and the type 
of chronic hypoperfusion used. All these explain why our intervention was to select a 
model to minimise an important rate of mortality in particular related to the anaesthesia 
and strain. It should, however, be noted that in the four publications in which Spraque-





















Age or weight Anaesthetic agents Mortality 
de la Torre et al., 1994: 




ketamine 100 mg/kg i.m. 
 
olders rats are not 
recommended because of 
increased mortality 
Liu et al., 
2005: male Wistar 
250 to 300 g (8 to 10 
weeks) 
10% chloral hydrate 
i.p. 
not stated 
Miyamoto et al., 2001: 
male Wistar 
 





25% (2/8) died in group 1, 25% 
(2/8) died in group 2, 22.2% 
(2/9) died in group 3, 16.7% 
(1/6 died) in group 4 
Ni et al., 1994: male 
Wistar 
6-9 months old 
 
pentobarbital 40 mg/kg 
i.p. 
11.5% (3 of 26) died within 24h 
after the BCCAO 
Kasparova et al., 2005: 
male Wistar 
 
250-350 g (3-6 months 
old and 15-16 months 
old were compared.) 
ketamine 50 mg/kg bw 
























Sopala and Danysz, 
2001: male SD 
 




citrate 0.315 mg/ml; 
fluanisone 10 mg/ml) 
 
3 controls and 2 occluded rats 
had died for 
unknown reasons within 16-
month 
Pappas et al., 1996: 
male SD 
 
500-600 g (9 to 10 
months of age) 
 
Ketamine 100 mg/kg 
i.m. and methoxital 
sodium 40mg/kg i.p. 
 
not stated 
Tanaka et al., 1998: 
male Wistar 
11 weeks pentobarbital 35 mg/kg 
i.p. 
36% (in 25 rats, 9 died) 
Davidson et al., 2000: 
male SD 
510-711 g (10 months 
old) 
Ketamine hydrochlore 













10% (4/40) rats died after 
vessel occlusion 
Wakita et al., 1994: 
male Wistar 
150-200 g sodium pentobarbital 25 
mg/kg i.p. 
13.7% (7/51) died 7 days after 
BCCAO 
de Wilde et al., 2002: 
male Wistar 
4 months isoflurane a week after surgery 21.7% of 
mortality 
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2.1.1.2.1 Choice of strain 
The Wistar rats present a complete circle of Willis which is important for the blood 
supply to the brain in a model of arterial occlusion. An incomplete circle of Willis may 
induce more pronounced ischaemic brain damage which may not “reproduce” the pattern 
of pathology observed in cerebrovascular diseases in patients who normally present a 
complete circle of Willis. The male Wistar rat is the strain most commonly used as the 
model of BCCAo; given the volume of ancillary data available in the Wistar rat 
publications, the strain was our obvious choice (table 2.2). 
 
2.1.1.2.2 Choice of the anaesthetic agent 
Wakita et al. (1994) used pentobarbital (an injectable barbituric) in their model of 
BCCAo (see table 2.2), however, this particular barbiturate leads to a significant 
respiratory depression and the duration of anaesthesia is extremely variable: from 10 
minutes to several hours in the mouse and 1 to 2 hours in rats. 
The combination of the injectable agents ketamine and xylazine induces anaesthesia; 
however, excessive doses of xylazine can provokes hypotension. 
Isoflurane anaesthesia is easier to control in a stable manner. A further advantage of 
isoflurane is that it induces anaesthesia rapidly (within minutes) and recovery is equally 
and post anaesthesia monitoring is of short duration compared to pentobarbital. 
This various elements led to the choice of a halogenated anaesthetic agent (isoflurane) in 




2.1.2 Stereotaxic injection of N-methyl-D-Aspartate (NMDA) in the brain 
Stereotaxic injections were performed to produce positive controls for MRI acquisition.  
From my master’s project (Khallout et al., 2007 unpublished data), I had already 
observed an increase of BBB permeability to Evan’s blue (960.82 Da), 24 hours after the 
injection of NMDA into the caudatoputamen. This extravasation increased at 48 hours. 
As it was essential to detect BBB permeability to Gadolinium (938 Da) during the T1-
MRI acquisition (and that the MRI parameters were correct), I chose to inject NMDA 
into the caudoputamen. Two days later, in the male Wistar rat, was scanned as a positive 
control to observe an increase of BBB permeability to the tracer. Strbian et al. (2008) 
demonstrated that the pattern of BBB permeability to Gadolinium and Evan’s blue in the 
ischaemic rat brain is similar.  
The rats were anaesthetized initially in an induction box containing 5% isoflurane in a 
nitrous oxide and oxygen mixture (70:30), then transferred to a David Kopf stereotaxic 
frame (Clark, Electromedical). A face mask was fitted over the snout and isoflurane was 
reduced to 2-2.5% for the remainder of the surgical procedure. Rectal temperature was 
monitored and maintained close to 37°C with the aid of heating lamps. 
A midline incision was made in the scalp which with the temporatis was retracted to 
reveal the surface of the skull, bregma and the interaural line. The muscles were retracted 
to reveal the right and left occipital bones, down to the base of the skull. A 2µl Hamilton 
syringe attached to the stereotaxic frame was aligned over bregma and then moved to the 
appropriate coordinates from the bregma. A burr hole was drilled over this area. The dura 
mater was incised by using a dural hook. Five minutes later, the needle was lowered 0.68 
mm ventrally from the surface of the brain. NMDA (Sigma) made in PBS (10mM, pH 
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7.4) was injected (75 nmoles of NMDA in 1.7μl PBS) into the caudatoputamen, at the 
rate of 0.1µl per minute. A total volume of 2µl was injected, and then the needle was left 
in place for a further five minutes. Then a second injection in of PBS (10mM, pH7.4) was 
done in the second hemisphere (controlateral) in an identical manner. The scalp was then 
sutured, anaesthesia discontinued and rats were monitored in their own cages with food 
and water ad libitum. 
Forty-eight hours later, the rats were re-anaesthetised and a catheter was introduced into 
the femoral vein for the injection of gadolinium prior to the MRI acquisitions. 
 
2.1.3 Pose of femoral vein catheter 
Following each specific time point after the onset of chronic cerebral hypoperfusion, the 
rats were anaesthetized in an induction box filled with 5% isoflurane in a 30% oxygen / 
70% nitrous oxide mixture, 20 minutes prior to the MRI session. When completely 
anaesthetized, a facemask was apposed and where anaesthesia was maintained with 2.0-
2.5% isoflurane. The right femoral vein was exposed and separated from the surrounding 
connective tissue and femoral artery. A small incision was made in the femoral vein 
compressed with silk thread to reduce flow. A polythene catheter (external diameter 0.96 
mm, internal diameter 0.58 mm diameter; SIMS Portex Ltd; 1 m long) containing 
heparinised saline was inserted 1 cm into the vein and then secured with 2/0 silk suture. 
Local anaesthetic (xylocaine) was applied to the incision site which was then sutured. 
The rat was then introduced into the MRI, under anaesthesia (2% isoflurane in a 30% 
oxygen / 70% nitrous oxide mixture). The head was fixed to the coil through ears bar. A 
rectal probe was inserted to allow temperature to be monitored. Animals were maintained 
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between 36.8 and 37°C during the MRI examination. Ventilation was monitored to assure 
a constant respiration. 
After the T2 sequence, MTI-MRI were acquired, 1 ml of Gadolinium (Gd-DOTA; 
gadoteric acid; DOTAREM; Guerbet) was administrated into intravenously, after the T1-
MRI baseline signal was acquired. 
The acquisition and analyses of the various MRI sequences are detailed later in sub-
chapter 2.4. 
 
2.1.4 Perfusion and fixation 
Animal were deeply anaesthetised in an induction box containing 5% isoflurane in a 30% 
oxygen / 70% nitrogen mixture, and then transferred to a facemask and isoflurane levels 
were reduced to 2% until the end of the procedure. An abdominal incision was made to 
reveal the diaphragm which was excised. The rib cage was reflected to expose the heart. 
A blunt needle attached to the perfusion system was inserted into the ascending aorta via 
the right atrium was pierced to allow the drainage of the venous return. Between 200-
300ml of heparinised saline (1ml heparin / 500ml saline) was administred until the 
perfusate ran clear. The rat then received 200-300 ml of 4% PFA until rigor. The head 
were removed and immersed in the PFA solution for 24 hours. The brain was then 






2.2.1 Paraffin processing and sectioning 
After post-fixation for 24 hours, the whole brains were placed in a rat brain matrix and 
were dissected coronally into slices of 3mm. The brain sections were dehydrated through 
a series of alcohols, cleared with xylene and then submerged in liquid paraffin at 60°C in 
an automated tissue processor. The brain sections were then embedded in small 
containers containing liquid paraffin, left to cool, then removed and mounted. Paraffin 
sections (6 µm thick) were cut on a microtome (Leica RM 2135) and mounted on poly-L-
lysine coated slides. Sections were taken at two locations, 0.20 and -3.30 mm from the 
bregma, based on the atlas of Paxinos and Watson (Paxinos and Watson, 1998). 
 
2.2.2 Haematoxylin and eosin staining 
Paraffin sections were placed in an oven at 60°C for 30 minutes, then in xylene for 15 
minutes to remove the wax, then the sections were rehydrated through a series of 
alcohols, 100% (2X 5mins) > 90% (2mins) > 70% (2mins) and then into tap water for 10 
minutes. 
Sections were immersed in haematoxylin (Thermo Scientific, Loughborough, UK) for 1 
minute, rinsed and placed in acid alcohol solution (1% hydrochloric acid in 70% ethanol) 
for 8 to 10 seconds to destain to a grey colour, then placed in Scott’s tap water (2% 
MgSO4, 0.35% NaHCO3) for 2 minutes to restablish the blue colour of the nuclei. The 
sections were placed in running tap water for 2 minutes and immersed in undiluted 
alcoholic eosin Y solution (Surgipath, Cambridgeshire, UK) for 2 minutes. Sections were 
then dehydrated through a series of alcohols, 70% (2mins) > 90% (2mins) > 100% (2X 
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5mins) and xylene (10 minutes) before being mounted with coverslips using DPX 
(Distrene, Plasticiser, Xylene). 
 
2.2.3 Counter staining with haematoxylin 
Paraffin embedded sections immunostained using the Iba-1 antibody were counterstained 
to enable the identification of anatomical landmarks. Following the DAB (3,3′-
diaminobenzidine) visualisation stage, sections were rinsed in water for 10 minutes and 
then placed in haematoxylin for 30 seconds. After a quick wash in water, the sections 
were placed in acid alcohol for 8 to 10 seconds, then in Scott’s tap water for 2 minutes, 
rinsed in water, dehydrated through a series of alcohols, cleared in xylene and mounted 
with coverslips using DPX. 
 
2.2.4 Quantification of ischaemic damage following BCCAo in the rat 
All histological analyses were conducted blindly over a two days interval. Sections were 
scored on both days and then the results compared to reduce the variability (see appendix 
A). Haematoxylin-and-eosin stained sections were used to assess the extent of ischaemic 
damage. Ischaemic neurons were defined by an intense, darkly stained pyknotic nucleus 
surrounded by an eosinophilic cytoplasm (fig. 2.2.B) while healthy neurons have large 
round nuclei and cell bodies with visible cytoplasmic structures (fig.2.2.A). The severity 
of damage to the perikarya was evaluated bilaterally in the hippocampus and in the 
caudatoputamen as: 0 = no ischaemic damage, 1 = little presence of ischaemic damage, 2 
= moderate ischaemic damage and 3 = extensive ischaemic damage.  
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Use of hematoxylin and eosin staining     
In well-controlled models of focal cerebral ischaemia, hematoxylin and eosin staining 
demonstrate early ischaemic damage (pyknosis and hyperchromicity) several hours after 
ischaemic injury (Armiger et al., 1977; Okuno et al., 2001). Meng and collaborators 
assessed the histopathology in the white and grey matter by two methods: the H&E 
staining procedure and TUNEL staining technique. They failed to find any differences in 
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Fig.2.2: Representative images of haematoxylin and eosin staining in the 
caudatoputamen after BCCAo. Normal neurons appear “round” with a visible cytoplasm 
and nucleus (A), while ischaemic neurons appear shrinked with a pink cytoplasm (B, C, 
D). 
The presence and extent of damage to perikarya (with pink cytoplasm) was graded as 
normal (grade 0) in A; scattered presence (B) of ischaemic neurons (grade 1); moderate 
numbers (C) of ischaemic neurons (grade 2); and near –total (D) ischaemic neurons 
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All sections used for immunostaining were adjacent to those which had undergone 
histological analysis and all analyses of immunohistochemistry were conducted blind 
over two days, sections were scored on both days and results then compared to minimize 
variability.  
 
2.3.1 General principles 
The immunohistochemistry technique is based on an antigen-antibody reaction to 
localise, within the tissue, the antigen. All immunohistochemistry in this thesis used the 
avidin-biotin complex (ABC) method to improve the sensitivity and resolution of the 
technique as well as the reaction between a chromogen (diaminobenzidene: DAB) and 
peroxidise to produce a brown deposit readily visible under light microscopy. The ABC 
method (Hsu et al., 1981) is an indirect method for antibody detection which exploits the 
high binding affinity of avidin, a large glycoprotein from egg whites, to biotin, a low 
molecular weight protein from egg yolks. 
 
2.3.2 Protocol 
Paraffin sections were placed in the oven at 60°C for 30 minutes, then in xylene for 10 
minutes to remove the wax, then the sections were rehydrated in absolute alcohol, 100% 
(2X 5mins) before being immersed in a blocking solution containing 3% dihydrogen 
hydrogen peroxide (Sigma) in 100% methanol for 30 minutes. The sections were then 
placed in running tap water for 10 minutes. A limited number of antibodies require one 
more step of antigen retrieval. Briefly, the sections were submerged in citric acid (10mM, 
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pH60) and microwaved on full power for 2X 5 minutes until boiling. Following a cooling 
period of 20 minutes, the sections were rinsed in PBS 2X 5minutes and then ringed with a 
hydrophobic pen (Vector Labs) before the “block” solution containing 10% normal sera 
and 0.5% bovine serum albumin (BSA) in PBS for 1 hour at room temperature. This step 
blocks the non-specific binding sites with the normal sera from the species in which the 
secondary antibody was raised. Then, the block solution is removed and the primary 
antibody (raised in an animal against the antigen of interest), diluted at appropriate 
concentration in PBS was placed at 4°C overnight. Details of the primary antibody 
concentrations, source, appropriate blocking solution and secondary antibody are 
described in table 2.3. On the second day, the sections were washed in PBS 2X 10 
minutes before receiving the biotinylated secondary antibody (raised against the species 
of animal that the primary antibody was made) in PBS for 1 hour at room temperature. 
Thereafter the sections were washed in PBS (2X 10 minutes) and then incubated with a 
solution of the avidin-biotin-peroxidase complex (Vector Laboratories, UK) made 
according the manufacturers instructions in PBS at room temperature for 1 hour. Sections 
were then washed in PBS (2X 10 minutes) and then incubated with DAB solution (Vector 
Laboratories) in distilled water again according to the manufacturer’s instructions for 3 
minutes to visualize the antibody binding. Sections were then dehydrated through a series 
of alcohols, 70% (2 minutes), 90% (2 minutes), 100% (2X 5 minutes) and xylene (10 
minutes) before being coverslipped in DPX. Negative controls were performed in all the 
immunohistochemical protocols by omitting the primary antibody with, as a result, 
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2.3.3 Quantification of axonal damage following BCCAo in the rat 
Amyloid precursor protein (APP) is the step in the metabolism/formation of the amyloid 
β/A4, which is accumulated in AD brains (Kang et al., 1987). APP is transported by fast 
anterograde axonal transport (Koo et al., 1990) and its accumulation indicates a 
disturbance in this transport (Gentleman et al., 1993). In regions where axonal damage 
occurrs, APP-rich structures are evident as dark, swelling, bulbous and dystrophic axons. 
The severity of axonal pathology was evaluated bilaterally by a semi-quantitative scale in 
the corpus callosum, the external capsule, the internal capsule, the optic tract and in the 
caudatoputamen, the method of quantification was based on those reported by Gentleman 
et al. (1995), Gleckman et al. (1999) and also Saatman et al. (2003), as: normal (grade 0), 
slight accumulation of APP (grade 1), moderate accumulation of APP (grade 2), and an 
extensive accumulation of APP (grade 3), see fig.2.3. 
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Fig.2.3: Representative images of APP accumulation (black dots) in the caudatoputamen 
after BCCAo. The presence of axonal damage was graded as absent (grade 0) in A; slight 
accumulation of APP (grade 1) in B; moderate accumulation of APP (grade 2) in C; and 























2.3.4 Quantification of myelin débris following BCCAo in the rat 
MAG is a constituent of myelin sheaths throughout the nervous system and is located in 
the periaxonal lamellae of myelin sheats. MAG is furthermore involved in cell-surface 
recognition (Poltorak et al., 1987) and has been identified as one of the first myelin 
proteins to suffer following ischaemia (Aboul-Enein et al., 2003).  
Myelin débris was assessed (fig.2.4) in the corpus callosum, the external capsule, the 
internal capsule, the optic tract and in the caudatoputamen as: absent, non-existant (grade 
0), slight accumulation of myelin débris (grade 1), moderate accumulation of myelin 
















Fig.2.4: Representative images of MAG staining in the optic tract after BCCAo. The 
degree of presence of myelin débris (black dots) was graded as absent (grade 0) in A; 
slight accumulation of myelin débris (grade 1) in B; moderate accumulation of myelin 
débris (grade 2) in C; and severe presence of myelin débris (grade 3) in D. The scale bar 




















2.3.5 Quantification of pathological microglial activation following BCCAo in the 
rat 
The ionized calcium-binding adaptor molecule 1 (Iba-1) is a protein highly and 
specifically expressed in microglia; Iba-1 plays a role in the regulatory action of activated 
microglia (Ito et al., 1998).  
Because of the difficulty to define with precision individual microglia cells within a 
tissue that has suffered, a semi-quantitative assessment scale was used. The amount of 
microglia activated was evaluated (Fig.2.5) as 0 = normal presence of activated 



















Fig.2.5: Representative images of Iba-1 staining in the caudatoputamen after BCCAo. 
The presence of activated microglia (in brown) was graded as normal compared to the 
sham (grade 0) in A; a moderate enhancement of activated of microglia (grade 1) in B; 
severe enhancement of microglial activation (grade 2) in C. The scale bar upper left 
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2.3.6 Evaluation of axonal damage, myelin débris, damage to the perikarya and 
microglial activation 
As stated earlier, the grey and white matter regions investigated bilaterally in the present 
study were located at +0.20 and -3.30 mm from the bregma, based on the atlas of Paxinos 
and Watson (Paxinos and Watson, 1998). The following regions (fig.2.6) were selected: 
corpus callosum, external capsule, fimbria, internal capsule, optic tract, caudatoputamen 
and hippocampus. To evaluate the extent and evolution of the pathology induced by 
carotid ligation, we calculated an individual overall score as: Sum (Σ) of each grade in 
each region of interest as noted in each hemisphere. A high score indicates widespread 











2.4 In vivo magnetic resonance imaging 
2.4.1 Principle 
Magnetic resonance imaging (MRI) is a non-invasive method used in radiology that 
provides detailed three-dimensional images and sectional anatomical precision inside an 
object. The technology is based on the physical phenomenon of nuclear magnetic 
resonance, namely to observe the nuclear magnetic resonance of protons in water 
contained in the body, i.e. the response of nuclei subjected to an external magnetic field 
and electromagnetic excitation. The intensity collected in a volume element (voxel) 
depends on the concentration of water at that location and so one obtains a three 
dimensional image of the distribution of water in the body. According to the method 
used, the contrast between two voxels can be increased if the relaxation times of nuclear 
spins (describing the return to equilibrium after excitation of nuclei) differ in both areas. 
It is therefore possible to observe alterations of tissues (such as tumours) due to 
differences in density and relaxation of water. 
All nuclei have a charge, and this charge turn around a nuclear axis and generates a 
magnetic dipole which is expressed by a quantity called magnetic moment (µ). In the 
absence of magnetic fields, the magnetic moments are not oriented. (Fig.2.7). 
 
 
Fig.2.7: Magnetic moment and its orientation in the absence of magnetic fields 
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In the presence of a static magnetic field, the magnetic moments take a given orientation 
which corresponds to a given energy state (Fig.2.8) 
 
 
Fig.2.8: Orientation of the magnetic moments in the presence of a magnetic field 
 
To observe the resonance, one must provide energy to allow the nuclei to move from 
their fundamental state to the excited state. This energy is supplied by a second magnetic 
field with intensity (~106) smaller than the previous one. 
Relaxation happens after the absorption of electromagnetic energy provided by the 
second magnetic field; the nuclei tend then to return to their equilibrium position. This 
relaxation can be decomposed into two phenomena: the longitudinal relaxation (T1) and 
the transversal relaxation (T2). 
The longitudinal relaxation called T1 relaxation corresponds to a return to the equilibrium 
energy of the system after excitation. The time constant T1 is defined as the time required 
for the protons to reach the two-thirds of their magnetisation. 
The transversal relaxation called T2 is normally defined as the time during which the 
intensity decreases by two-thirds of its initial value. 
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Fig.2.9: Relaxation times of T1 (A) and T2 (B) measurements. 
 
The relaxation times T1 and T2 of tissues depend (fig. 2.9) on the mobility of hydrogen 
nuclei present in these tissues: the relaxation time increases with the hydration of these 
tissues and decrease when the hydration decreases. Indeed, an acute lesion, accompanied 
in most cases with inflammation and oedema, increases the amount of water in these 
tissues.  
 
MRI is based on the differences in T1 and T2 and the proton density (water content and 
mobility of water molecules) in tissue and it detects signal from mobile (free) water 
protons (with long T2). The T2 relaxation time of less mobile water protons (bound) 
associated with macromolecules and membranes are too short to be detected in MRI (see 
fig. 2.10). 
MTI is based on the magnetization interaction between water protons and 
macromolecular-bound protons. If an off-resonance radio frequency is applied to the 
macromolecular protons, the saturation of these protons is transferred to the water protons 





transfer between tissue macromolecules and water. With MTI, the presence or absence of 
macromolecules (e.g. in membranes or brain tissue) can be detected. 
The magnetization transfer ratio (MTR) is the difference in signal intensity with or 
without magnetization transfer. A lesser MTR within a region compared to the control 
indicates a decreased density of macromolecules (tissue or membranes…) to exchange 
magnetization with the surrounding water molecules. It thus reflects a presence of 
damage (Iannucci et al., 2001; Wolff and Balaban, 1989). 
 
 


















2.4.2 Experimental design 
The experimental design is illustrated in figure 2.11. Rats were divided into two groups 
either of three hours or of seven days survival time following the BCCAo. After the 
imposed post-intervention delay, the rats were introduced into the tunnel for the MRI 
acquisitions. Each animal received an injection of gadolinium (Gd-DOTA; gadoteric 
acid; DOTAREM; Guerbet) before the MRI acquisition of T1, to measure the integrity of 





Fig.2.11: Experimental design for MRI acquisition at either three hours or seven days following BCCAo 
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2.4.3 MRI scans 
Following the pose of the femoral venous catheter, the rats were placed in a MRI 
compatible holder (Rapid Biomedical, Wurzburg, Germany). Rectal temperature and 
respiration were monitored and controlled throughout the examination (SA 
Instruments Inc., Stony Brook, NY, US) to ensure normal and stable physiological 
parameters. MRI data were obtained with a Varian 7T preclinical scanner (Varian 
Inc., Oxford, UK) fitted with a 72 mm volume coil and a phased array rat brain coil 
(Rapid Biomedical).  
The MRI acquisitions were performed by Dr Maurits Jansen and Mr Gavin Merrifield. 
Dr Mark Bastin processed the T2 and T1 images and the MTI images were processed 
into MTR parametric maps. I then analysed blindly the MRI images through the use 
of ImageJ software (V1.43). Means gray values per sections for each region were 
measured and compared the two controls and two BCCAo groups.  
Each full MRI examination lasted 1 hour and included the undernoted sequences: 
 T2 high resolution (structural scan) 
 MTI (white matter integrity) 
 Baseline for T1 
 Injection of Gd 
 T1 (BBB integrity) 
 
Nineteen contiguous slices were imaged in T2 for detailed structural resolution with a 
field-of-view of 2626 mm, an acquisition matrix of 192X192 and slice thickness of 
0.8 mm; the acquisition voxel dimension was 0.20.20.8 mm. The repetition (TR) 
and echo (TE) times for each fast spin-echo volume were 3000 and 36 ms.  
The T1 acquisition was done to measure BBB integrity with gadolinium as a tracer. 
Again, nineteen contiguous slices were imaged with a field-of-view of 2626 mm, an 
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acquisition matrix of 128X128 and slice thickness of 0.8 mm; the acquisition voxel 
dimension was 0.20.20.8 mm. The TR and TE for each fast spin-echo volume were 
780 and 9.48 ms.  
The MT-MRI protocol employed two spin-echo sequences (TR 2300 and TE 12.52 
ms) with identical acquisition parameters as for the T1; one was acquired with a 
magnetization transfer pulse applied 3 kHz off resonance. 
 
2.4.4 Image analysis 
After the acquisitions were processed by Dr Mark Bastin, I selected regions-of-
interest (ROI) as detailed by Iannucci and collaborators (2001) and I manually 
delineated, with ImageJ (version 1.43) software, the corpus callosum (Fig.2.12 A-E-
I), the caudatoputamen (Fig.2.12 B-F-J), the external capsule (Fig.2.11 C-G-K) and 
the internal capsule (Fig.2.12 D-H-L) in both hemispheres on the T2-weighted images 
(A to D), MTR maps (E to H), and T1-weighted images (I to L). Each area was 
measured through ImageJ. Mean grey values obtained from ImageJ (see appendices B 
and D) were compared (MTR) between each BCCAo and appropriate sham group. 
The signal enhancement (as a percentage) of gadolinium was compared for the T1-
weighted images, as explained below (section 2.4.5 and appendices C and D).  
To reduce variability, a second analysis was undertaken two days after the initial and 





     
     
     
       
 
 
Fig.2.12: Coronal MRI images to show the ROIs selected within the corpus callosum 
(A, E, I), the caudatoputamen (B, F, J), the external capsule (C, G, K) and the internal 
capsule (D, H, L), delineated by red boundries, in the T2-weighted images (A-D), 
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Fig.2.13: First and second assessment of T2, MTR and T1 analyses done on different 
























2.4.5 Measurement of BBB permeability 
A healthy brain capillary with an intact BBB is not permeable to the contrast agent 
(Gd-DOTA) which remains intravascular, while a capillary in sufferance with a 
disrupted BBB will become permeable to the agent and leads to an accumulation of 
the contrast agent in the neuropil. Accordingly, the measurement of the signal 
enhancement of Gd-DOTA signal may be used as an indicator of BBB dysfunction.  
The mean grey values were obtained by ImageJ after selecting the structure as 
described above. The mean grey value before Gd-DOTA injection represents the 
baseline. Then the percentage of signal enhancement of Gd-DOTA compared the 
baseline was calculated as follows for each brain region selected (see appendices C 
and D): 
Signal enhancement of Gd-DOTA (%) = (Mean grey value after Gd-DOTA injection 
– Mean grey value before Gd-DOTA injection)* 100 / (Mean grey value before 
injection). 
 
2.5 Western blotting 
The western blots and RT-PCR as well as their statistical analyses were performed by 
Dr Severine Launay and Miss Abigail Herrmann. I performed all the surgerical 
interventions and to allow the extraction of the brain tissues by Dr Severine Launay. 
Western blotting techniques were used to determine the levels of caspase-3, MMP-2 
(metalloproteinase-2), VEGF (vascular endothelial growth factor) and HIF-1α 
(hypoxia inducible factor 1-α) in BCCAo and sham rats at three hours and seven days 
after the surgery. After each time point, the rats were anaesthetized (5% isoflurane in 
a 30% oxygen/70% nitrous oxide mixture). When deeply anaesthetized, the rats were 
decapitated and brains were removed from their skull. Three brain regions were 
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extracted on dry ice: the cortex, the corpus callosum and the caudatoputamen. The 
two half-brains were separated to use one for the western blot analysis and the other 
for the RT-PCR analysis. 
All brain structures were homogenised in a buffer consisting 9 M urea, 4% CHAPS (a 
zwitterionic detergent that protects the native state of proteins - Sigma, C9426) and 
complete protease inhibitor cocktail (Sigma) and centrifuged at 10,000 rpm for 10 
minutes. The supernatants were recovered and stored at -80°C until required. Each 
sample was assayed for protein concentration by the Bradford method. Samples were 
denatured at -70°C for 10 minutes before separation on 4-12% Bis-Tris gel 
(Invitrogen) at 80 V for 150 minutes. Proteins were electro-transferred (30V, 1 hour) 
on to a nitricellulose membrane (Biorad). After blocking (10 ml Odyssey blocking 
buffer, 10 ml PBS), membranes were incubated overnight with blocking solution 
containing either Hif1-α, Caspase-3, VEGF, MMP-2 (see table 2.4). After washing six 
times for five minutes in PBS/0.1% Tween-20 solution, the membranes were 
incubated for 1 hour with the appropriate 680 and 800 IR (Infrared) dye secondary 
antibodies (1:50000, LI-COR Biosciences). The membranes were washed again with 
PBS/0.1% Tween-20 solution with a final wash carried out in PBS alone. The 
membranes were imaged through the use of Odyssey infrared imaging system, 






























Abcam 1 in 1000 
MMP2 Rabbit 
Polyclonal 
Abcam 1 in 1000 
GAPDH Rabbit 
Polyclonal 





Abcam 1 in 20 000 
 
Table2.4: Antibodies used for western blots 
 
2.6 Real-Time PCR 
Real-time quantitative PCR (RT-PCRq) is derived from classic PCR (Polymerase 
Chain Reaction). The main difference is that RT-PCR allows the visualization of the 
quantity of neosynthetized DNA for each PCR cycle and not only the product 
obtained at the end of the reaction. 
RT-PCR allows the detection and precise quantification of a fluorescent emitter, 
SYBR Green I (Applied Biosystems) which is able to insert itself in double-stranded 
DNA. This dye emits light only when bound to double-stranded DNA. The increase of 
fluorescence is directly proportional to the quantity of generated amplicons during the 
PCR reaction. Therefore, with specific nucleotidic primers, this technique is able to 
quantify the amplification of target genes. 
RT-PCR was used in this study to determine the gene expression of Hif1-α, VEGF 
and Caspase-3 in three forebrain structures: the cortex (neocortex), the corpus 
callosum and the caudatoputamen after seven days of BCCAo. 
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2.6.1 Preparation of PCR primers 
Gene specific primers are retrieved from the online PrimerBank database 
(http://pga.mgh.harvard.edu/primerbank/). These primers are then ordered from the MGH 
(Massachussets General Hospital) DNA Core Facility. All the primers are desalted and both 
UV absorbance and capillary electrophoresis are used to assess the quality of primer 
synthesis.  
 
2.6.2 Reverse Transcription-PCR 
RNA from rat half-brain structures were prepared according to the SuperScript First-
Strand Synthesis System for RT-PCR as per the manufacturer’s protocol (Invitorgen). 
A 10 μl of RNA/primer mixture was prepared for each tube which included 5 μg of 
total RNA, 3 μl (50 ng/μl) of random hexamers, 1 μl of 10mM dNTP mix and 
completed to 10 μl with DEPC (Diethylpyrocarbonate) treated water. Thereafter, the 
samples were incubated at 65C for five minutes and then put on ice for at least one 
minute.  
A reaction master mixture was then prepared to include 10x RT buffer, 4 μl of 25mM 
MgCl2, 2 μl of 0.1 M dithiothreitol, 1 μl of RNaseOUT (Recombinant Ribonuclease 
Inhibitor). The reaction mixture was then added to the RNA/primer mixture, briefly 
mixed, and then placed at room temperature for two minutes. Then 1 μl of 50 units of 
SuperScript II RT was added to each tube, mixed and incubated at 25C for 10 min. 
The tubes were then incubated at 42C for 50 minutes, heat inactivated at 70C for 15 
minutes and then chilled on ice. One μl of RNase H was added to remove the RNA 
template and incubated at 37C for 20 minutes. The first strand cDNA was then stored 
at -20C until use for real-time PCR. 
Nucleic acids of interest were amplified by RT-PCR with cDNA as the template. 
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Real-time PCR were achieved by an ABI Prism 7000 Sequence Detection Systems 
(Applied Biosystems). Reactions were carried out in microcentrifuge tubes in a 
thermocycler (Bio-Rad) with a range of cycling conditions. Hot-start PCR was 
performed with the SYBR Green PCR Master Mix (Buffer, dNTPs, polymerase, 
MgCl2, SYBR Green I) (Applied Biosystems) In brief, the PCR mixtures [12.5 l 
SYBR Green Mix (2x), 0.2 l liver cDNA, 1 l primer pair mix (5 pmol/l each 
primer), 11.3 l of water] were pre-heated at 50C for two minutes and then 95C for 
10 minutes for an initial denaturation and activation of the polymerase, to be followed 
by 40 cycles of amplification (95C for 15 seconds; 60C for 30 seconds; 72C for 30 
seconds). A final extension step was performed at 72C for 10 minutes. α-Tubuline 
and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were used as internal 
markers. The PCR products were checked by 3% agarose gel with an aliquot of 5 l 
from each reaction. The real-time PCR results were then analyzed with the SDS 7000 
software to check if there was a bimodal dissociation curve or abnormal amplification 


























NM_031836.1 For ACCCACGACAGAAGG 
Rev ACAGGACGGCTTGAA 
 





NM_022298.1 For CAAGCGACAAGACCAT 
Rev TGCGAACTTCATCAATAAC 
 
    
Table 2.5: Primers used for RT-PCR 
 
 
2.6.3 Real-Time PCR 
Quantitative SYBRgreen RT-PCR was performed on an Opticon Monitor 
thermocycler machine to validate the results obtained from the Affymetrix® gene 
array. Three hours or seven days following BCCAo, the structures from the other half-
brain (cortex, corpus callosum and caudatoputamen) of BCCAo and sham-operated 
rats was dissected on ice-cold phosphate buffered saline (pH 7.4 PBS, NaCl 137mM, 
KCl 2.7mM, NaH2PO4 1.4mM, Na2HPO4 4.3mM) and immediately frozen on dry ice 
and stored at -70°C.  
mRNA was isolated from those structures and cDNA synthesized as previously 
described in section 2.6.2.  
One μl of cDNA was added to 24 μl of mastermix containing: 0.5μl of each 
appropriate primer (12.5μM), 10.5μl bidistilled water and 12.5 μl of 2 X SYBRgreen 
RT-PCR mix (Applied Biosystems). Two serial dilution series of BCCAo or sham 
cDNA and a blank control that contained no reverse transcriptase cDNA synthesis 
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products were performed in each experiment. The Opticon Monitor RT-PCR machine 
was programmed with an initial incubation at 50C for 2 minutes and then 95C for 
10 minutes for a denaturation and activation of the polymerase followed by 40 cycles 
of amplification (95C for 15 seconds; 60C for 30 seconds; 72C for 30 seconds). A 
final extension step was performed at 72C for 10 minutes.   
 
2.7 Statistical analyses 
2.7.1 Histopathology 
Comparisons between groups (sham and BCCAo rats) in terms of axonal damage, 
myelin débris accumulation, neuronal perikaryal damage and microglial activation 
were assessed by Mann-Whitney’s test. The histopathological grade of all the regions 
of interest were summated to give an overall score per animal and then scores were 
compared. All calculations were based on GraphPad Prism (version 5.03 for 
Windows). 
 
2.7.2 MRI analyses 
To determine if BCCAo-induced white matter alterations, based on the MTI 
acquisitions, every selected regions of BCCAo rats were compared to the same region 
in sham-operated rats by an unpaired t-test. 
The comparison in the same rat of % signal enhancement of Gd-DOTA, according to 
the brain structure, was calculated using an ANOVA-repeated measure followed by a 
Bonferroni post-test, by comparing the baseline to the time after Gd injection, in both 
groups (BCCAo and sham). The comparison between the BCCAo and sham group 
was done using a 1 way-ANOVA. 
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2.7.3 Western blots and RT-PCR analyses 
Western blot data and RT-PCR results were analyzed by unpaired t-tests on GraphPad 
Prism 5.03. 






























CHAPTER 3: Results 
 
3.1 Temporal sequence of pathological events after BCCAo 
 
The rats were divided randomly into groups at three hours, three days, seven days, 14 
days and 28 days after BCCAo, as well as a control group (sham) for each time 
interval. The procedure was performed on a total of 96 rats (54 BCCAo and 42 sham). 
Among the BCCAo rats, one rat died within 24h; one rat died within three days of 
ligation and one rat died seven days after BCCAo. The overall mortality rate was 
approximately 6%. Prior to death, these rats presented with a decreased mobility and a 
tendency to isolate themselves from the others in the same cage. All BCCAo animals 
lost 15 to 18% of their original body weight from the second to the fourth day post 
surgery, and then recovered slowly to regain their original weight by seven to 28 days 
after the surgical intervention. No morbidity and mortality were noted in the sham 
rats. 
 
3.1.1 BCCAo-induced axonal damage 
The control (sham) rats that underwent the procedure without occlusion of the 
common carotid arteries showed no axonal pathology in the seven selected regions. 
Axonal damage after BCCAo was identified by the presence of intense APP 
immunoreactivity in swollen or bulbous axons (McKenzie et al., 1996). In the occluded 
groups, APP accumulation was detected as sonn as three hours after the surgery until 
28 days post occlusion. At three hours post occlusion, APP accumulation was 
predominantly detected in the corpus callosum (fig.3.1B and 3.1F) and in the external 
capsule (Fig.3.1E). Five out of nine BCCAo rats exhibited axonal damage in the 
corpus callosum and six out of nine BCCAo rats exhibited axonal damage in the 
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external capsule. The fimbria, the internal capsule and the caudatoputamen also 
exhibited some APP accumulation. Axonal damage was not detected either in the 
hippocampus or in the optic tract in any of the three-hour BCCAo group. Table 3.1 
presents the number of rats in which APP accumulation was detected in the selected 
regions as a function of time of the delay following BCCAo. The quantification of 
axonal damage in all of those (bilateral) seven regions shows that, after three hours of 
occlusion, BCCAo effected significantly (p<0.01) axonal damage, absent in the sham-
operated group (Fig.3.6). We need to underline the fact that the pattern of axonal 
damage after three hours of BCCAo differs in the same group. Some brain structures 
may exhibit more or less damage according to each animal. The figure 3.1B present 
APP accumulation in the corpus callosum of one BCCAo animal while in another 
BCCAo animal the degree of axonal damage in the corpus callosum differs, as it can 
be seen in the figure 3.1F. This indicates that the BCCAo procedure does not 
reproduce the same pattern of damage for each animal. After three days post 
occlusion, axonal damage was detected in the hippocampus, in the corpus callosum, in 
the external capsule, in the fimbria, in the internal capsule, in the optic tract (fig.3.2 
D) and in the caudatoputamen (fig.3.2 B). The regions which most of the animal 
exhibited axonal damage after three days post BCCAo were the caudatoputamen (five 
out of nine animals), the internal capsule (four out of nine animals) and the optic tract 
(six out of nine animals). The sham group did not present any APP accumulation 
(fig.3.2A and C). The induction of chronic cerebral hypoperfusion for three days leads 
to significant (p<0.001) axonal damage in the BCCAo group compared to the sham 
group (Fig.3.6). At 7 days post BCCAo, axonal pathology was more important and 
was detected in the hippocampus, in the corpus callosum, in the external capsule, in 
the fimbria, in the internal capsule, in the optic tract (Fig.3.3 D) and in the 
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caudatoputamen (fig.3.3B and E). The optic tract and caudatoputamen being the 
regions that exhibited the more axonal damage at this time point. Seven days of 
BCCAo induced more significant (p<0.001) axonal damage compared to the control 
group (Fig.3.6). After 14 days post BCCAo, the hippocampus, the corpus callosum, 
the external capsule, the internal capsule, the optic tract (Fig. 3.4D) exhibited axonal 
pathology; the fimbria was the only region that did not present any APP 
accumulation. The presence of axonal pathology in the BCCAo group was 
significantly (p<0.001) different from the control group (Fig.3.6). The optic tract and 
the caudatoputamen were the regions that exhibited the more axonal pathology at 14 
days post occlusion. However, the damage at 14 days post BCCAo is less important 
than at seven days post BCCAo. At 28 days post BCCAo, axonal damage was 
detected in the corpus callosum, in the external capsule, in the hippocampus, in the 
fimbria, in the internal capsule, in the optic tract (Fig.3.5D) and in the 
caudatoputamen. The optic tract is the region where axonal damage was the most 
prominent in terms of time-related injury following BCCAo. Vacuoles present in the 
corpus callosum and in the optic tract (red arrows in B and D). After 28 days of 





















Hippocampus 0/9 1/9 3/12 1/10 2/11 
Caudatoputamen 3/9 5/9 9/12 6/10 4/11 
Corpus callosum 5/9 2/9 5/12 2/10 6/11 
External capsule 6/9 3/9 5/12 1/10 5/11 
Fimbria 4/9 2/9 2/12 0/10 2/11 
Internal capsule 4/9 4/9 11/12 3/10 9/11 
Optic tract 0/9 6/9 11/12 10/10 10/11 
 
Table 3.1: Number of rats in which an increase in APP accumulation was detected in 


















Fig.3.1: APP immunostaining in the corpus callosum (A, B, F), in the optic tract (C 
and D) and in the external capsule (E) following three hours of BCCAo. APP 
accumulation appears as dark dot (see arrows in B, E and F). No APP accumulation 
was detected in the sham-operated rats (A and C) or in the optic tract after three hours 







Fig.3.2: APP immunostaining in the caudatoputamen (A and B) and in the optic tract 
(C and D) following three days of BCCAo. No APP staining was detected in the sham 
group. Arrows in B and D indicate the presence of APP accumulation. Scale bars in 













Fig.3.3: APP immunostaining in the caudatoputamen (A, B and E) and in the optic 
tract (C and D) following seven days of BCCAo. APP accumulation appears as dark 
dot (see E and arrows in B and D). No APP accumulation was detected in the sham 
group (A and C) after seven days of BCCAo. Axonal damage appears to be more 






Fig.3.4: APP immunostaining in the corpus callosum (A and B) and in the optic tract 
(C and D) following 14 days of BCCAo. No APP accumulation was detected in the 
sham group after 14 days of BCCAo. Arrows in D indicate APP accumulation in the 




Fig.3.5: APP immunostaining in the corpus callosum (A and B) and in the optic tract 
(C and D) following 28 days of BCCAo. Red arrows show presence of vacuolizations 
in the corpus callosum (B) and optic tract (D) 28 days post BCCAo. APP aggregates 


















   
Fig.3.6: Extent of axonal damage with time (∑ grade of bihemisphere regions) 
following   BCCAo.  
Quantification of axonal damage in the APP immunostained sections. Data are 
presented with their median. **P<0.01, ***P<0.001 for comparison with the sham 
group. (Non parametric Mann-Whitney test). The number of rats in each group was: 
Three hours sham, n=8; three hours BCCAo, n=9; three days sham, n=9; three days 
Bccao, n=9; seven days sham, n=8; seven days BCCAo, n=12; 14 days sham, n= 8; 14 















3.1.2 BCCAo-induced myelin pathology 
Stained sections revealed organised networks of myelinated fibres (see black line 
drawn in fig.3.9A). After chronic cerebral hypoperfusion, myelin débris was detected 
in areas where myelin sheaths were lost as attested by vacuolisations (red arrow in 
fig.3.7B and 3.9B). The sham group, that had the surgery without the occlusion of the 
both common carotid arteries, exhibited also some débris of myelin that may be due to 
the background of the staining, or to the surgery when separating the vagus nerve 
from the common carotid artery; Fazan and Lachat (1997) showed that injury to the 
vagus nerve causes myelin damage in the rat. The table 3.2 presents the number of 
animals where myelin débris was detected in the selected regions. 
After three hours of BCCAo, all white matter regions of interest exhibited myelin 
débris presented as dark dots (see black arrows) with presence of vacuolisations. 
Between the sham and the BCCAo group, the difference was significant (p<0.05) 
(Fig.3.12). Three days post occlusion, the damage to the myelin was more intense 
within each region, especially in the optic tract (Fig.3.8B). The presence of myelin 
débris in the BCCAo group was significantly (p<0.001) different from the sham group 
(fig.3.12). One more time, we can easily see how the fibers are organised in the optic 
tract of a sham (fig.3.8A) while in the optic tract of a three days post BCCAo, the 
organisation of myelin sheats is lost and the presence of myelin débris and 
vacuolisations increased (fig 3.8B) compared to the sham. Seven days post BCCAo, 
we noted an increase of myelin débris within the selected regions with more damage 
in the optic tract. Myelin débris (dark arrows) and vacuolisations (red arrows) were 
detected (see fig.3.9B). The BCCAo group was significantly different from the sham 
group (p<0.001) after seven days of occlusion (fig. 3.12). After 14 days post BCCAo, 
myelin débris was detected in all white matter regions (see table 3.2) and the 
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difference between the control and occluded group was significant (p<0.01) 
(Fig.3.12). 28 days post occlusion the damage remained severe in all white matter 
regions. The difference between the BCCAo and sham group was significant 
(p<0.001) (Fig.3.12). 
Those results show that BCCAo causes significant damage to axon and myelin, both 
components of the white matter, from three hours to 28 days. 
 










Caudatoputamen 1/9 7/9 11/12 9/10 11/11 
Corpus callosum 8/9 6/9 12/12 3/10 11/11 
External capsule 8/9 8/9 12/12 7/10 11/11 
Fimbria 2/9 9/9 9/12 8/10 10/11 
Internal capsule 9/9 9/9 12/12 10/10 11/11 
Optic tract 9/9 9/9 12/12 10/10 11/11 
 
Table 3.2: Number of rats in which an increase in myelin débris was detected in the 








Fig.3.7: MAG immunostaining of the corpus callsoum (A and B) and optic tract (C 
and D). Myelin débris appear as dark dots (see black arrows). The staining also shows 
the presence of vacuolizations (red arrows in B) three hours after BCCAo compared 














Fig.3.8: MAG immunostaining showing myelin débris which appear as small black 
dots (B) and presence of vacuolizations and disarrangements of fibres that occur in the 
optic tract following three days of BCCAo. The fibre organisation in the optic tract of 
the sham is well organised while in the BCCAo animal the presence of vacuolizations 







Fig.3.9: MAG immunostaining in the optic tract following seven days of BCCAo. 
Presence of vacuolizations (see red arrows in B) that occur in the optic tract appear to 








Fig.3.10: MAG immunostaining showing myelin débris which appear as small black 
dots (B) and presence of vacuolizations and disarrangements of fibres that occur in the 
optic tract following 14 days of BCCAo. The fiber organisation in the optic tract of 
the sham is well organised (see black line drawn on fig.3.10A) while in the BCCAo 
animal, the fiber of the optic tract are less organised due to the presence of 







Fig.3.11: MAG immunostaining showing myelin débris (see black arrow in B) 
vacuolizations (in B see red arrow) and disarrangements of fibres that occur in the 







Fig.3.12: Extent of myelin pathology with time (∑ grade of bihemispheric regions) 
following BCCAo.  
Quantification of myelin débris in the MAG immunostained sections. Data are 
presented with their median. *P<0.05, **P<0.01, ***P<0.001 for comparison with 
the sham group. (Non parametric Mann-Whitney test).  
The number of rats in each group was: 
Three hours sham, n=8; three hours BCCAo, n=9; three days sham, n=9; three days 
Bccao, n=9; seven days sham, n=8; seven days BCCAo, n=12; 14 days sham, n= 8; 14 

























3.1.3 BCCAo-induced enhancement of microglial activation 
Iba-1 immunostained sections revealed a minimal presence of enhancement of 
activated microglia in the sham group (Fig.3.13A-C), which can be explained by the 
surgery and the removal of the common carotid artery from the connective tissue that 
include the common carotid artery with the vagus nerve.  
The quantification of those slides revealed that after three hours of occlusion, there 
was no enhancement of activated microglia compared to the sham (Fig.3.18) in all the 
regions of interest. At this stage, ramified microglia do not have the morphology of 
macrophages. Three days post occlusion, significant (p<0.001) enhancement of 
activated microglia was detected in the Iba-1 immunostained sections of the BCCAo 
group compared to the sham. The caudatoputamen and the optic tract being the 
regions that exhibited the more enhancement of activated microglia. After seven days 
of BCCAo, the enhancement of activated microglia was significantly (p<0.001) 
different from the control group (Fig.3.18). The caudatoputamen and the optic tract 
being the regions that exhibited the more enhancement of microglial activation 
detected in most of BCCAo rats (table 3.3). Enhancement of activated microglia 
appears to be more important in the caudatoputamen (B) and optic tract (D) compared 
to the sham (A and C). Moreover, the ramifications in microglia present in the 
caudatoputamen of BCCAo rats (fig.3.15B) seem to be more important than those 
detected in the sham rats (fig.3.15A). This may indicates a change in the phenotype 
process of transition of microglia to macrophages with a possible recruitement of 
leukocytes from the bloodstream (see fig.3.15E). 
14 days post BCCAo, the enhancement of activated microglia was substantial in all 
the regions with a significant difference (p<0.05) compared to the sham group 
(Fig.3.18). The figure 3.16B shows microglia in close contact with endothelial 
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cerebral vessel which may indicate that the stage of leukocytes recruitement from the 
bloodstream may continue after 14 days post BCCAo. 28 days post occlusion the 
level of enhancement of microglial activation was detected, being significantly 
different (p<0.01) to the control group (Fig.3.18). The few level of microglia was 
observed in the fimbria while the optic tract was the region exhibiting the more 
enhancement of microglial activation compared to the control, associated with many 
vacuolisations, indicative of white matter damage (Fig.3.17D). At this stage, 
microglia phenotype had probably changed. The figure 3.17B may show 
macrophages. Those results showed that after three hours of BCCAo, no enhancement 
of activated microglia was observed compared to the sham group. It is from three days 
post BCCAo that a significant difference in term of enhancement of activated 
microglia compared to the sham group was detected, until 28 days post BCCAo. 
Interestingly, the regions, which most animal present enhancement of microglial 
activation with time post BCCAo, are the caudatoputamen, the internal capsule and 






















Hippocampus 0/9 0/9 3/12 10/10 2/11 
Caudatoputamen 0/9 6/9 11/12 10/10 4/11 
Corpus callosum 0/9 2/9 3/12 10/10 3/11 
External capsule 0/9 2/9 3/12 10/10 3/11 
Fimbria 0/9 0/9 3/12 10/10 1/11 
Internal capsule 0/9 4/9 7/12 10/10 6/11 
Optic tract 0/9 5/9 12/12 10/10 10/11 
 
Table 3.3: Number of rats in which an increase in enhancement of microglial 




Fig.3.13: Iba-1 immunostaining of microglia (brown) in the caudoputamen (A and B) 
and in the optic tract (C and D) following three hours of BCCAo. Microglia (see 

















Fig.3.14: Iba-1 immunostaining of microglia (brown) in the caudoputamen (A and B) 
and in the optic tract (C and D) following three days of BCCAo. At this stage 
oligodendrocytes appear to be still organised in the optic tract of BCCAo rats (D). 

















                                                      
                                                 
 
Fig.3.15: Iba-1 immunostaining of microglia (brown) in the caudoputamen (A and B) 
and in the optic tract (C and D) following seven days of BCCAo. Enhancement of 
activated microglia appears to be more important in the caudatoputamen (B) and optic 
tract (D) compared to the sham (A and C). The close contact to the vessel of microglia 
(black arrow in E) may lead to a recruitement of leukocytes from the bloodstream (red 





Fig.3.16: Iba-1 immunostaining of microglia (brown) in the caudoputamen (A and B) 
and in the optic tract (C and D) following 14 days of BCCAo. Picture B shows 
microglia in close contact with endothelial cells of the vessel which can indicate a 
possible recruitement of leukocytes. Oligodendrocytes (which appears in blue dark) in 
the optic tract of sham (C) are aligned while in BCCAo rats (D) oligodendrocytes are 
not aligned which indicates disarrangements of fibres. Microglial activation appears to 













Fig.3.17: Iba-1 immunostaining of microglia (brown) in the caudoputamen (A and B) 
and in the optic tract (C and D) following 28 days of BCCAo. At this stage the 
phenotype of microglia in the caudatoputamen of BCCAo rats (B) seems to be 
different than the one in the sham (A). In B it is probably macrophages. Scale bars in 


















Fig.3.18: Extent of enhancement of microglial activation with time (∑ grade of 
bihemispheric regions) following BCCAo.  
Quantification of microglial activation in the Iba-1 immunostained sections. Data are 
presented with their median. *P<0.05, **P<0.01, ***P<0.001 for comparison with 
the sham group. (Non parametric Mann-Whitney test). 
The number of rats in each group was: 
Three hours sham, n=8; three hours BCCAo, n=9; three days sham, n=9; three days 
Bccao, n=9; seven days sham, n=8; seven days BCCAo, n=12; 14 days sham, n= 8; 14 


























3.1.4 BCCAo-induced damage to neuronal perikarya 
H&E stained sections were used to quantify ischaemic neurons (section 2.2.4), in the 
hippocampus and in the caudatoputamen. Damage to the perikarya of the neurons are 
defined by an intense darkly stained pyknotic nucleus surrounded by eosinophilic 
cytoplasm while healthy neurons have large round nuclei and cell bodies visible 
cytoplasmic structures. After three hours of BCCAo, no ischaemic neurons were 
detected (see fig.3.19) neither in the hippocampus, nor in the caudatoputamen (table 
3.4). Three days post occlusion, some animals exhibited ischaemic neurons in the 
caudatoputamen and in the hippocampus (fig.3.20B). Only three rats out of nine 
exhibited damage to the perikarya of neurons in the caudatoputamen, while one rat 
out of nine presented no ischaemic neuronal parikaryal damage to the hippocampus 
(table 3.4), hence no significant difference was observed between the control (sham) 
and BCCAo group (Fig.3.24). After seven days of BCCAo, the damage to the 
perikarya of neurons was detected in the hippocampus and being more intense in the 
caudatoputamen (Fig.3.21). Knowing that ten out of twelve rats exhibited neuronal 
perikaryal damage, the difference between the control and the BCCAo group was 
significant (p<0.005) (Fig.3.24). This result indicates that hippocampus is not the area 
that is preferably damage after BCCAo. 14 days post occlusion, five out of ten rats 
presented damage to the perikarya of neurons (Fig.3.24), mainly found in the 
caudatoputamen (five out of ten rats) while only one out of five who present 
ischaemic damage has neuronal parikaryal damage to the hippocampus (table 3.4 and 
fig.3.22), but this was not sufficient to find any statistical differences between the 
sham and BCCAo group (Fig.3.24). 28 days post occlusion (fig.3.23), the number of 
rats that exhibited ischaemic damage was less to what we found previously knowing 
that four out of eleven rats only (see table 3.4) exhibited ischaemic neuronal 
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perikaryal damage. Thus, no significant difference was observed between the control 
and BCCAo group (Fig.3.24). 
Those data suggest that the chronic cerebral hypoperfusion model lead to a minimal 
detection of ischaemic neurons at three, 14 and 28 days. However, this experiment 
revealed two interesting times point: after three hours of permanent BCCAo, no 
damage to the hippocampus and/or caudatoputamen was detected, while severe 
neuronal perikaryal damage was observed seven days post BCCAo. Secondly, the 
hippocampus seems to be better preserved than the caudatoputamen with time post 
BCCAo. Indeed, only few animals exhibited ischaemic neuronal damage with time. 
The number of ischaemic neurons appears to be reduced with time post BCCAo, 
which may be explained either by the fact that microglial cells act as “housekeepers” 
by cleaning up ischaemic cell death, which may lead to the conclusion that less 
ischaemic damage was present, just because we cannot detect them. Or this can also 
be explained by the fact that the BCCAo model change with time and animals. 
 










Hippocampus 0/9 2/9 3/12 1/10 2/11 
Caudatoputamen 0/9 3/9 10/12 5/10 4/11 
 
Table 3.4: Number of rats in which an increase in ischaemic neuronal perikaryal 








Fig.3.19: H&E staining in the Ca1 area: monolayer of the hippocampus (A-B) and in 
the caudatoputamen (C-D) following three hours post BCCAo. Scale bars in A, B, C, 




Fig.3.20: H&E staining in the Ca1 area: monolayer of the hippocampus (A-B) and in 
the caudatoputamen (C-D) following three days post BCCAo. Ischaemic neuronal 
perikaryal damage can be clearly observed (see black arrows in B). Healthy neurons 
should appear as round with a clear nucleus and cytoplasm (see blue arrow in A). 
Ischaemic neurons appear with a shrinked cytoplasm (see arrows in D) and an intense 








Fig.3.21: H&E staining in the Ca1 layer of the hippocampus (A-B) and in the 
caudatoputamen (C-D) following seven days post BCCAo. Ischaemic neurons have a 
shrunken cytoplasm and are intensely hyperchromatic (black arrow in B) compared to 
adjacent healthy neurons with their round, clear nuclei (blue arrow in B). Scale bars in 

















Fig.3.22: H&E staining in the Ca1 area: monolayer of the hippocampus (A-B) and in 
the caudatoputamen (C-D) following 14 days post BCCAo. (B-D X100). Further 

















Fig.3.23: H&E staining in the Ca1 area: monolayer of the hippocampus (A-B) and in 
the caudatoputamen (C-D) following 28 post BCCAo. Further details are given in the 




















Fig.3.24: Extent of neuronal perikaryal damage with time (∑ grade of bilateral 
regions) following chronic cerebral hypoperfusion. Quantification of H&E stained 
sections. Data are presented with their median. **P<0.005 for comparison with the 
sham group. (Non parametric Mann-Whitney test). 
Sham 3 hours, n=8; Bccao 3 hours, n=9; Sham 3 days, n=9; Bccao 3 days, n=9; Sham 
7 days, n=8; Bccao 7 days, n=12; Sham 14 days, n= 8; Bccao 14 days, n=10; Sham 28 



























Previous studies on chronic cerebral ischaemia, lacunar infarction or arterial 
hypertension (Feigin an Popoff, 1963; Tomimoto et al., 1996; Akiguchi et al., 1997) 
have postulated that white matter damage is related to BBB dysfunction (Wardlaw, 
2010). These hypotheses explain why vascular dysfunction is critical in 
cerebrovascular diseases. BCCAo is a well-characterised model amd especially so at 
later time point. Nonetheless, the literature is sparce with respect to changes of BBB 
integrity during chronic cerebral hypoperfusion. Some authors have shown significant 
changes within the periventricular area of the corpus callosum at three days after 
BCCAo (Sood et al., 2008; Ueno et al., 2002). Shin and collaborators have 
demonstrated an increase of claudin-3 immunoreactivity without an explicit 
discussion as to whether is associated with changes or not in terms of permeability of 
the BBB. Indeed, it has been demonstrated that increases in claudin-3 expression 
interfere and, consequently, decrease the permeability of the tight junctions (Coyne et 
al., 2003; Wolburg et al., 2003). On the other hand, chronic inflammatory stress 
increased BBB permeability and claudin-3 expression (Brooks et al., 2005). Because 
SVD are almost synonymous with hypoperfusion of the brain, it remains to be 
established if BBB permeability is responsible for the damage to the white matter at 
precocious (three hours post BCCAo) time-points and if BBB integrity may be 
perturbed seven days after BCCAo, the time at which we observed the most severe 











3.2 BBB integrity after BCCAo in the rat model using MRI  
 
3.2.1 NMDA positive control for BBB permeability 
Three anaesthetized adult male Wistar rats (280-320g) were injected NMDA into one 
hemisphere (ipsilateral) and a PBS injection into the other hemisphere (contralateral).  
The Hamilton tracks in the brain can be observed in the T2 structural image (fig.3.25 
and 3.26 A) by the increase in permeability of the BBB to the gadolinium next to the 
injection site in both hemispheres (contralateral and ipsilateral). That latter can be 
detected on the T1 image which shows the signal enhancement of gadolinium 
(Fig.3.26 B). However, the introduction of the needle containing the solution of 
NMDA into the ipsilateral cortex leads to a significant enhancement of gadolinium 
signal (p<0.001) compared to the contralateral cortex (fig.3.26 E) in the three animals. 
The volume of increased gadolinium density was visually greater with the excitotoxic 
agent (NMDA) than with the physiological vehicle (PBS). 
 
 
Fig.3.25: T2-weighted structural images to show the injection of NMDA into one 
hemisphere (ipsilateral) and PBS in the other hemisphere (contralateral) in the three 




Figure 3.26F represents data from one rat; the two other had an injection limited to the 
temporal cortex (see fig.3.25, on T2 images acquisitions). The data from one animal 
(fig.3.26 F) compares the caudatoputamen which received the NMDA injection 
(ipsilateral) with the caudatoputamen which received the PBS injection 
(contralateral). 
The IgG immunostained sections at the level of the caudatoputamen revealed an 
uptake of the IgG into the perikarya of the ipsilateral caudatoputamen (Fig.3.26 C), 
while no such uptake was observed in the contralateral caudatoputamen (fig.3.26 D). 
The measurement of the gadolinium enhancement showed a significant difference 
between the ipsilateral and contralateral caudatoputamen, which indicates an increase 























Fig.3.26 (p.114-115): Positive control of BBB permeability 48 hours after NMDA 
injection in the caudatoputamen. The arrows show the injection site of NDMA in the 
ipsilateral hemisphere and the injection site of PBS in the controlateral hemisphere. 
A: T2 structural image showing the location of the needle introduction (see arrows). 
B: T1 image showing gadolinium extravasation into the parenchyma (see arrows). C: 
IgG immunostained section in the ipsilateral side of the caudatoputamen (which 
received NMDA injection) to reveal the neuronal uptake of IgG (black arrows). D: 
IgG immunostained section in the contralateral caudatoputamen (which received the 
PBS injection) showing no IgG diffusion inside the neurons. E: Significant 
(***P<0.001) Gadolinium signal enhancement with time after NMDA injection in the 
ipsilateral cortex compared to the injection of PBS in the contralateral cortex. Data are 
presented with their means (n=3) by a one-way ANOVA with repeated measures. F: 
Gadolinium signal enhancement with time which is more marked after NMDA 
injection in the ipsilateral caudatoputamen than after the injection of PBS into the 









Signal enhancement of gadolinium with time
in the ipsilateral cortex (with NMDA injection)
compare to the contralateral cortex (with PBS injection)























































Signal enhancement of gadolinium with time
in the ipsilateral caudatoputamen (with NMDA injection)
compare to the contralateral caudatoputamen (with PBS injection)
F 
*** P<0.001  
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3.2.2 MRI acquisitions after BCCAo in the rat 
 
In the previous study, after three hours of BCCAo only white matter damage was 
detected by immunohistochemistry, while grey matter and enhancement of activated 
microglia appeared after three days of BCCAo. The most severe damage in both white 
and grey matter was found after seven days of BCCAo. This explains why three hours 
and seven days were chosen to study the integrity of the BBB using MRI. Is an 
increase of BBB permeability responsible of the damage to the white matter detected 
at three hours post BCCAo using immunohistochemistry? 
Twenty-six male Wistar rats underwent the procedure of chronic cerebral 
hypoperfusion (section 2.1.1), and were separated into two major groups: three hours 
post occlusion (seven rats control and seven rats which underwent the BCCAo 
procedure) and seven days post occlusion (six rats control and six rats which 
underwent the BCCAo procedure). I have chosen four regions (corpus callosum, 
caudatoputamen, external capsule and internal capsule) to undergo the analyses (as 
described in section 2.4.5) on T1-weighted images (see Appendices C, D) and on 











3.2.2.1 MTR measurements 
3.2.2.1.1 Regional MTR variations after three hours of BCCAo 
The MTR of the BCCAo and sham group at three hours post surgeries showed 
significant regional differences between brain regions (Fig.3.27 e). MTR was highest 
in the corpus callosum, external capsule and internal capsule, and it was lowest in the 
caudatoputamen. The MTR of grey matter structure was significantly lower 
(p<0.0001) than that of white matter (fig.3.27 e). However, no significant differences 
in MTR was found between the two groups, showing that after three hours, BCCAo 
did not show any differences in white matter physiology compared to the control 
































Fig.3.27: MTR values BCCAo compared to sham rats following three hours 
intervention (a, b, c, d). Data are presented with their means (Unpaired t-test). Sham 3 
hours, n=7; BCCAo 3 hours, n=7. No significant difference was found between sham 
and BCCAo groups. 
(e): Regional MTR variations: corpus callosum (CC), caudatoputamen (CP), external 








3.2.2.1.2 Regional MTR variations after seven days of BCCAo 
The MTR of the two groups at seven days post surgery showed significant regional 
differences between brain regions (Fig.3.28). MTR was highest in regions in which 
white matter predominates such as the corpus callosum, the external capsule and the 
internal capsule. MTR was lowest in the caudatoputamen which is a mixed white/grey 
matter region. Indeed, the MTR of the caudatoputamen was significantly lower 
(p<0.0001) than that of white matter (fig. 3.28e). However, no significant differences 
in MTR was found between the two groups (sham and BCCAo) which would indicate 
that, at seven days post BCCAo, MTI acquisitions failed to reveal any differences in 







































Fig.3.28: MTR values BCCAo compared to sham rats following three hours 
intervention (a, b, c, d). Data are presented with their means (Unpaired t-test). Sham 7 
days, n=6; BCCAo 7 days, n=6. No significant difference was found between sham 
and BCCAo groups. 
(e): Regional MTR variations: corpus callosum (CC), caudatoputamen (CP), external 
capsule (EC) and internal capsule (IC).  
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3.2.2.2 MRI-T1 acquisitions related to the integrity of the BBB 
3.2.2.2.1 MRI-T1 acquisition at three hours post BCCAo 
After three hours of BCCAo (or their appropriate sham-operated rats), the 
gadolinium-induced enhancement of the MRI-acquired signal was calculated, from 
the T1 images, in selected regions-of-interest as described in section 2.4.5 of the 
methods chapter. The data are presented in figure 3.29. No significant differences 
were found compared to the sham-operated group, in any of the four selected regions. 
 
3.2.2.2.2 MRI-T1 acquisition at seven days post BCCAo 
The procedure described above (3.2.2.2.1) was repeated in two groups of rats studied 
seven days after sham or BCCAo interventions. In BCCAo rats, an enhancement of 
the gadolinium signal was detected in all the four chosen regions. In all, the 
gadolinium signal was found to be greater than in the sham group and significant 
deifferences between the BCCAo and the sham group were observed in the 









                
                 
Fig.3.29: Evolution of the gadolinium-induced increase in signal as a function of time (min) following administration of the paramagnetic tracer. 
Three hours after intervention both sham (open circles, black, n=7) and BCCAo (filled squares, red, n=7) rats were studied. The horizontal bars 
represent the meam group values. There were no differences between groups either as a function of time or region (tests explained in section 
2.7.2). 
Gd-induced signal enhancement three hours after BCCAo 
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Fig.3.30: Evolution of the gadolinium-induced increase in signal as a function of time (min) following administration of the paramagnetic tracer. 
Seven days after intervention both sham (open circles, black, n=6) and BCCAo (filled squares, red, n=6) rats were studied. The horizontal bars 
represent the meam group values. Significant differences between groups were found as a function of regions: in the caudatoputamen (p<0.05) 
and in the external capsule (p<0.01). (Tests explained in section 2.7.2). 
** P<0.01  
* P<0.05  
Gd-induced signal enhancement seven days after BCCAo 
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3.2.3 Histology and Immunohistochemistry assessment 
3.2.3.1 Axonal pathology after four hours post surgery 
Following three hours of occlusion, the rats underwent the MRI scans with duration of 
45 to 60 minutes per animal. So the perfusion which occurred one hour later the MRI 
scan led us to analyse a pathology of four hours post BCCAo, and not three hours. 
 
After the onset of BCCAo, the APP immunostained sections revealed that 3/6 animals 
presented APP accumulation (see table 3.5). No significant differences (fig.3.31) were 
observed between the two groups (sham and BCCAo).  
 






Hippocampus 0/6 0/6 
Caudatoputamen 1/6 3/6 
Corpus callosum 1/6 1/6 
External capsule 2/6 3/6 
Internal capsule 0/6 0/6 
Optic tract 0/6 1/6 
 
Table 3.5: Number of rats in which an increase in APP accumulation was detected in 




                 
Fig.3.31: Extent of axonal damage with time (∑ grade of bilateral regions) following 
four hours of BCCAo. Quantification of APP accumulation. Data are presented with 
their median for comparison with the sham group. (Non parametric test with Mann-
































3.2.3.2 Axonal pathology after seven days post surgery 
Seven days following surgery, the APP immunostained sections revealed that 3/6 
animals which underwent the permanent BCCAo present APP accumulation. No 
animals of the control group presented any APP accumulation. The table below 
exposes the regions where APP accumulation (Fig.3.32a D) was detected (table 3.6). 
No significant differences were found between the two groups (Fig.3.32b). 
 






Hippocampus 0/6 0/6 
Caudatoputamen 0/6 2/6 
Corpus callosum 0/6 1/6 
External capsule 0/6 0/6 
Internal capsule 0/6 0/6 
Optic tract 0/6 1/6 
 
Table 3.6: Number of rats in which an increase in APP accumulation was detected in 


















Fig.3.32: a) APP immunostaining (X200) in the corpus callosum (A and B) and in the 
caudatoputamen (C and D) following seven days of BCCAo (B and D) or Sham (A 
and C). b) Extent of APP accumulation with time (∑ grade of bilateral regions) 
following seven days of BCCAo. Quantification of APP accumulation. Data are 
presented with their median for comparison with the sham group. (Non parametric 




3.2.3.3 Enhancement of microglial activation after four hours post surgery 
Iba-1 immunostained sections revealed an enhancement of activated microglia in the 
sham group (Fig.3.33). The quantification of those slides (section 2.3.6) revealed that 
after 4 hours of occlusion, there were no differences compared to the sham (Fig.3.33). 
 
 
             
 
Fig.3.33: Extent of enhancement of microglial activation with time (∑ grade of 
bilateral regions) following four hours of BCCAo. Quantification of presence of Iba-
1. Data are presented with their median for comparison with the sham group. (Non 






















3.2.3.4 Enhancement of microglial activation following seven days post surgery 
Seven days following the procedure of permanent BCCAo, the Iba-1 immunostained 
sections (Fig.3.34a) revealed some enhancement of activated microglia in the sham 
group, which can be due by the number of procedure that a rat underwent (surgery for 
the separation of the common carotid arteries from the vagus nerve, then the 
introduction of the catheter in the femoral vein seven days later which was followed 
by the MRI scans of an hour). The Mann-Whitney test showed a significant difference 









Fig.3.34: a) Iba-1 immunostaining in the caudatoputamen following seven days of 
BCCAo (B) or Sham (A). b) Extent of enhancement of microglial activation with time 
(∑ grade of bilateral regions) following seven days of BCCAo. Quantification of 
presence of Iba-1. Data are presented with their median **P<0.01 for comparison 
with the sham group. (Non parametric Mann-Whitney test). Sham 7 days, n=6; Bccao 








3.2.3.5 Neuronal perikaryal damage after four hours post surgery 
 
H&E stained sections were used to quantify ischaemic neurons (section 2.2.3), in the 
hippocampus and in the caudatoputamen. Damage to the perikarya of neurons are 
defined by an intense darkly stained pyknotic nucleus surrounded by eosinophilic 
cytoplasm while healthy neurons have large round nuclei and cell bodies visible 
cytoplasmic structures. 
After four hours of BCCAo, no ischaemic neurons were detected neither in the 
hippocampus, nor in the caudatoputamen. Therefore no differences with the control 




Fig.3.35: Extent of neuronal perikaryal damage (∑ grade of bilateral regions) 
following four hours of BCCAo. Quantification of presence of ischaemic neurons. 
Data are presented with their median for comparison with the sham group. (Non 














3.2.3.6 Neuronal perikaryal damage after seven days post surgery 
After seven days of BCCAo, damage to the perikarya of neurons was not detected in 
the hippocampus but only in the caudatoputamen, where 3/6 BCCAo rats exhibited 
ischaemic neurons (Fig.3.36a B). The difference between the sham and the BCCAo 
group was not significant (Fig.3.36b). 
 
 
Fig.3.36: a) H&E staining in the caudatoputamen following seven days of BCCAo 
(B) or Sham (A). b) Extent of neuronal perikaryal damage (∑ grade of bilateral 
regions) following seven days of BCCAo. Quantification of presence of ischaemic 
neurons. Data are presented with their median for comparison with the sham group. 
(Non parametric test with Mann-Whitney test). Sham 7 days, n=6; Bccao 7 days, n=6. 
Scale bars in A, B: 20µm. 
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This is the first study to assess the integrity of the BBB at earlier time point using 
MRI. Moreover, it is the first study that showed an increase of Gadolinium signal 
enhancement in the caudatoputamen and in the external capsule, in the rat model of 
permanent BCCAo. The results suggest that permanent BCCAo does not in itself 
induce an increase of BBB permeability, but the presence of damage and activated 
microglia may play a role in the modulation of the properties of the BBB. . I then 
hypothesize that the damage to the white matter may be due by some factors 
expressed in an environment of decrease of blood supply related to a decrease of 
oxygen and glucose leading to a hypoxic statement. It is well known that under 
hypoxic conditions, hypoxic inducible factor-1α (HIF-1α) is expressed and its 
overexpression causes apoptosis (Krick et al., 2005) by activating different factors 
including p53, p21, (Greijer and Van der Wall, 2004; Carmeliet  et al., 1998), 
caspase-3, vascular endothelial growth factor (VEGF) and matrix metalloproteinases 
(MMPs) (Narumiya et al., 2001). Increased VEGF has been detected at 24 hours and 
seven days of chronic cerebral hypoperfusion and its expression is mainly associated 
with endothelial cells in Sprague-Dawley rats (Hai et al., 2003). Also, the protein 
tumor necrosis factor (TNF)-α is increased at six and 24 hours after cerebral 
ischaemia (Haddad et al., 2006). Neurons and microglias are major sources of TNF-α 
which leads to oedema formation and demyelination under ischaemic conditions 
(Selmaj and al., 1988; Taupin et al., 1997). 
If we add to our results those informations, it may give a better understanding of 
possible mechanisms in white and grey matter pathology and their inter-relationships. 
Certainly, the damage in the white matter is not induced by the activation of the 
microglia per se, but the injury to the perikarya can be due, in part, to activated 
microglia which produce TNF-α and can differentiate into cytotoxic cells (Banati et 
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al., 1993); this sequence then leads to perikarya damage. Moreover, it has been 
demonstrated that matrix metalloproteinase-2 (MMP-2) plays a major role in chronic 
cerebral hypoperfusion (Nakaji et al., 2006) and that after 3 days of hypoperfusion, 
the expression of MMP-2 induces microglial activation (Ihara et al., 2001; Wakita et 
al., 2002). Also, MMP-2 increases the permeability of the BBB by disrupting the tight 
junctions (Yang et al., 2007).  
It is then from our interest to check the expression of those factors after BCCAo in the 
male wistar rat to have a better understanding of the damage that occurs in the white 



















3.3 Proteins implicated in the pathology of white matter in 
the rat model of chronic cerebral hypoperfusion  
 
Rats were divided randomly into two groups at three hours and seven days after 
BCCAo, as well as a control group (sham) for each time (section 2.1.1). The 
procedure was performed on a total of 29 rats (15 BCCAo and 14 sham). One rat 
among the BCCAo group died within 24h. (See Appendix E for full runs of western 
blots). 
 
3.3.1 Western blot analysis of protein levels following hypoperfusion 
 
3.3.1.1 HIF-1α Western blotting 
Western blot analysis of HIF-1α levels in the cortex, corpus callosum and in the 
caudatoputamen in a hemi-brain detected no change in response to hypoperfusion 
between sham and BCCAo after seven days (fig.3.37). However, a variation of HIF-
1α levels between cortex, corpus callosum and caudatoputamen can be noted 
following three hours of BCCAo.  
 
3.3.1.2 VEGF Western blotting 
 
Western blot analysis of VEGF levels in the cortex and in the corpus callosum in a 
hemi-brain detected no change in response to cerebral hypoperfusion between sham 
and BCCAo animals after three hours or seven days post surgery (fig. 3.38 and 3.39). 
Between three hours and seven days, VEGF levels are doubled in the cortex and 
increased in the corpus callosum in both sham and BCCAo groups. 
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3.3.1.3 Caspase-3 Western blotting 
 
Western blot analysis of caspase-3 levels in the in the cortex, corpus callosum and in 
the caudatoputamen in a hemi-brain detected no change in response to hypoperfusion 
between sham and BCCAo, in any of the regions examined (fig.3.40 and 3.41). In the 
corpus callosum, caspase-3 levels are half-reduced between three hours and seven 
days following surgery, in botth sham and BCCAo groups. 
 
3.3.1.4 MMP-2 Western blotting 
 
Western blot analysis of MMP-2 levels in the in the cortex and corpus callosum 
(fig.3.42) as well as in the caudatoputamen (fig.3.43). The tissues from the cortex and 
corpus callosum were studied at three hours, the cortex and caudatoputamen at seven 
days following either sham or BCCAo intervents. No occlusion-related changes in 
























Fig.3.37: HIF-1α Western blot analysis in the cortex, the corpus callosum and 
caudatoputamen of a half-brain, seven days following intervention (sham or BCCAo). 









Fig.3.38: VEGF Western blot analysis in the cortex and the corpus callosum of a half-
brain, three hours following intervention (sham or BCCAo). The horizontal lines in 























Fig.3.39: VEGF Western blot analysis in the cortex and the corpus callosum of a half-
brain, seven days following intervention (sham or BCCAo). The horizontal lines in 















Fig.3.40: Caspase-3 Western blot analysis in the cortex and the corpus callosum of a 
half-brain, three hours following intervention (sham or BCCAo). The horizontal lines 

















Fig.3.41: Caspase-3 Western blot analysis in the cortex, the corpus callosum and in 
the caudatoputamen of a half-brain, seven days following intervention (sham or 







Fig.3.42: MMP-2 Western blot analysis in the cortex and the corpus callosum and 
caudatoputamen of a half-brain, three hours following intervention (sham or BCCAo). 

























Fig.3.43: MMP-2 Western blot analysis in the cortex and the corpus callosum and 
caudatoputamen of a half-brain, seven days following intervention (sham or BCCAo). 













3.3.2 Gene expression of proteins which may be implicated in white and grey 
matter injury following hypoperfusion 
 
3.3.2.1 Expression of HIF-1α mRNA 
RT-PCR analysis of HIF-1α expression in the cortex, corpus callosum and in the 
caudatoputamen in a hemi-brain detected no change in response to hypoperfusion 
between sham and BCCAo, in any of the regions examined (fig.3.44 A). 
 
3.3.2.2 Expression of Caspase-3 mRNA 
RT-PCR analysis of caspase-3 expression in the cortex, corpus callosum and in the 
caudatoputamen in a hemi-brain detected no change in response to hypoperfusion 
between sham and BCCAo, in any of the regions examined (fig.3.44 B). 
 
 
3.3.2.3 Expression of VEGF mRNA 
RT-PCR analysis of VEGF expression in the cortex, corpus callosum and in the 
caudatoputamen in a hemi-brain detected significant change in response to 


















                                        
Fig.3.44: RT-PCR analysis of HIF-1α mRNA (A), Caspase3 mRNA (B) and VEGF mRNA (C) in the cortex, corpus 
callosum and in the caudatoputamen seven days post surgery. The samples were taken from one hemisphere.
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CHAPTER 4: Discussion 
BCCAo is a model – or paradigm – of neurodegenration within the brain (and retina – 
vide infra) that has been widely studied over several decades. There are, as of now, 
approximately 1000 articles referenced in the literature. A pertinent and recent review 
covered the 107 publications that focused on the BCCAo-induced vascular cognitive 
impairement to further our understanding of vascular dementia in man. The 107 
studies were divided into 16 distinct animal models (Jiwa et al., 2010). 
Their review opens avenues for future investigations. For example, the 
neuropsychological impairement listed were primarily deficits in working and 
reference memory. Vascular cognitive impairement encompasses a variety of 
cerebrovascular diseases such as small vessel disease, multi-infarct dementia, focal 
stroke, arteriopathy and many other disease states. However, the most-used model 
was that of BCCAo to provoke chronic cerebral hypoperfusion and its related but 
poorly defined white matter injury. It is on the basis of this abundant literature that 
our thesis has attempted to unravel the temporal modifications in the different cell 
types in the CNS following BCCAo. 
 
General considerations 
Different studies have compared the histological changes produced by BCCAo in 
white and/or grey matter, but none has compared the progression of damage between 
them. The studies performed in this thesis have indicated the vulnerability of white 
and grey matter to permanent ligation of both common carotid arteries with time, as a 
model of SVD. Initially, axonal and myelin pathology preceding microglial activation 
and perikaryal damage were characterised in the present model. An increase of 
permeability of the BBB in the BCCAo model was not detected at earlier time point 
 147 
through the use of MRI, but at only after seven days of BCCAo which leads to the 
conclusion that the damage observed in white matter at earlier time points is not due 
to an increase of BBB permeability. Finally, the apoptotic pathway does not seem to 
be a cause of white matter damage at three hours or seven days post BCCAo, but a 
significant expression of VEGF was detected at seven days post BCCAo, which can 
be associated with the increase of BBB permeability that we detected in MRI at seven 
days post BCCAo. 
Differing temporal patterns of neuropathological changes in the adult male Wistar rat 
were noted after the experimental induction of BCCAo. Marked dissimilarities exist 
in the evolution of histological damage within and between the white and grey matter 
structure selected for the study. Random patterns between animals and within the 
same group were also observed. This dispersion can be explained by variations of the 
blood supply as well as the different anastomoses that exist in some rat brains but not 
in others (Otori et al., 2003). Indeed, the “normal” circle of Willis in the rat is found 
in a minority of anatomical specimens; same is the case in man (Alpers et al., 1959). 
The decrease in weight during the first two days after the induction of BCCAo can be 
also explained by the blood supply via the external carotid artery which supplies the 
neck, the face, the tongue, and the lips. A decrease in external carotid blood flow 
could impair the apparatus of mastication and hence lead to a disturbance in food 
uptake. 
 
BCCAo causes white matter damage 
Several studies have already shown, in the permanent BCCAo model, that chronic 
cerebral hypoperfusion induces white matter damage in the adult rat (Wakita et al., 
2002; Wakita et al., 2003). Only two papers (Wakita el al., 2002 and Wakita et al., 
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2003) have focused on axonal damage induced by BCCAo. Theu have shown that 
axonal damage was apparent at one day in the corpus callosum, in the internal capsule 
and in the caudatoputamen and that only traces of axonal damage were observed in 
the optic tract after one hour of BCCAo (Wakita et al., 2002). These data support our 
findings, in that, even after three hours of occlusion, no axonal damage was detected 
in the optic tract, whereas, at the same time, the corpus callosum, the external capsule, 
the fimbria, the internal capsule and the caudatoputamen exhibited clear axonal 
damage. The fact should be underlined that, after three hours of BCCAo, myelin 
débris was detected in the optic tract. It has been shown that the first anoxia-induced 
pathological change in the white matter was periaxonal damage in the myelin sheaths 
(Waxman et al., 1992). The antibody that we used, raised against the myelin 
associated glycoprotein (MAG), was chosen to detect this protein localised in the 
periaxonal region of the myelin sheath. A primarly loss of MAG has been found in 
multiple sclerosis, in virus encephalitis and in acute stroke-induced lesions, whereas 
the other proteins of myelin were well preserved (Aboul-Enein et al., 2003). Those 
data can explain the dichotomy between the detection of myelin damage but not 
axonal damage in the optic tract after three hours of BCCAo. 
The damage in white matter regions appeared to be more pronounced from three days 
to 28 days after BCCAo. White matter regions exhibited a varying degree of 
vulnerability to BCCAo, with the optic tract being the most severely and time-related 
rarefied region. This predisposition of this structure can also be explained by its blood 
supply from the ophthalmic artery and the anterior cerebral artery which are branches 
of the internal carotid artery. 
Based on these results, the hypothesis arose that myelin damage occurs prior axonal 
damage after three hours of BCCAo in the optic tract; the myelin seems to be more 
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sensitive than the axons themselves after an abrupt and sustained decrease in carotid 
blood flow. 
 
BCCAo causes neuronal perikaryal damage 
The present data suggest that the perikarya (cell bodies of neurons) were spared in the 
first three hours following BCCAo but, at later time intervals of three, seven, 14 and 
28 days, displayed those hyperchromatic and pyknotic changes that are characteristic 
of ischaemia-induced insults, presenting a severe pattern of damage after seven days 
of BCCAo.  
The number of animals at three hours and three days is the same and, despite no 
significant difference between the sham and BCCAo group of three days, neuronal 
perikaryal damage was detected from this time point, not before. 
Both axonal and myelin damage was observed in several white matter structures: 
corpus callosum, external and internal capsules, the fimbria and the optic tract. The 
absence at three hours of histological damage in the perikarya of neurons and the 
presence of white matter injury, at this time point, allows the conclusion that white 
matter pathology precedes grey matter damage in the BCCAo model. The analysis of 
the blood flow data in the literature (see fig.2.1) suggests that flow is reduced by 
approximately 50% on the minutes following occlusion. Even if (and this is 
debatable) the flow was measured in the seconds following the simultaneous clamping 
of both common carotid arteries, then the theoretical reduction would be 
approximately 70% (i.e. the “intercept”) of the regression analysis. What to make of 
these facts? The flow decreases are severe and greater than these achieved in 
psychological situations such as voluntary hyperventilation to induce severe arterial 
hypocapnia. However decreases in flow of the order -50 to -70% are not severe and 
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severe enough to provoke early ischaemic changes in cortical neurons (i.e. perikaryal 
damage) (Kuroiwa et al., 1985; Somjen et al., 1988). 
 Other arguments may be adduced. In neonatal rats, a model of hypoxia-
ischaemia (i.e. a massive ischaemic insult), it has been shown that white matter injury 
precedes grey matter damage at one hour after hypoxia-ischaemia and that damage 
was apparent in both grey and white matter 24 hours later (Meng et al., 2005). 
Interestingly, Meng and collaborators assessed the histopathology in the white and 
grey matter by two methods: the H&E staining procedure and TUNEL staining 
technique. They failed to find any differences in terms of positive reesults, between 
the two staining methods used (Meng et al., 2005). 
 
BCCAo enhances the activation of microglia 
Previous studies have demonstrated that microglial activation is increased from seven 
to 30 days post BCCAo (Wakita et al., 1994) and after three months of BCCAo; this 
augmentation was related to white matter injury (Farkas et al., 2004). However, there 
are no publications in which the state of microglial activation has been addressed at 
earlier time points and none has compared the progression with time of the damage in 
relation to the pattern of white and grey matter pathology. It is of note that activated 
microglia were enhanced (i.e. modified phenotype) from three days to 28 days after 
BCCAo when compared to time-matched shams. A change in microglial morphology 
was not observed after three hours of BCCAo compared to the sham group. At seven 
days post BCCAo, all the animals of the BCCAo group showed an important 
enhancement of microglial activation and also marked damage within the white and 
grey matters. 
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Those results indicate that the presence of white matter damage does not seem to be 
initially due to an enhancement of microglial activation. Certainly, the damage in the 
white matter is not induced by an enhancement of microglial activation per se, but the 
damage to the perikarya can be due, in part, to a magnification of activated microglia 
that can differentiate into cytotoxic cells (Banati et al., 1993); this possible sequence 
then may lead to perikaryal damage. As was observed, white matter pathology is more 
important at later time points, a sequence which may be explained by the production 
of TNF-α from both microglia and dying neurons which then exacerbates the damage 
to the white matter (Banati et al., 1993). The protein, tumor necrosis factor (TNF-α) is 
increased at six and 24 hours after cerebral ischaemia (Haddad et al., 2006). The 
ischaemic damage in the perikarya of neurons and the enhancement of microglial 
activation, both expressing TNF-α, may exacerbate the pathology to white and grey 
matter (Selmaj et al., 1988; Taupin et al., 1997). Neurons and microglia are major 
sources of TNF-α which leads to oedema formation and demyelination under 
ischaemic conditions (Selmaj et al., 1988; Taupin et al., 1997).  
Moreover, it has been demonstrated that matrix metalloproteinase-2 (MMP-2) plays a 
major role in chronic cerebral hypoperfusion (Nakaji et al., 2006) and that, after three 
days of hypoperfusion, the expression of MMP-2 induces microglial activation (Ihara 
et al., 2001; Wakita et al., 1994). MMP-2 increases the permeability of the BBB by 
disrupting the tight junctions (Yang et al., 2007). Increased VEGF has been detected 
at 24 hours and seven days of chronic ischaemia and its expression is principally 
associated with endothelial cells in Sprague-Dawley rats (Hai et al., 2003). Both the 
expression of MMP-2 and VEGF lead to an increase in the permeability of the BBB. 
In the present investigation it is not improbable that the white matter injury seen three 
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hours after BCCAo was secondary to, or associated with, an increased permeability of 
the BBB. 
 
BBB permeability to gadolinium as assessed by MRI 
Studies done on patients with Binswanger’s disease (characterized by cerebrovascular 
white matter lesions (Caplan, 1995)) and in patients with periventricular 
hyperintensities but no dementia, Hanyu and colleagues (2002) demonstrated, with 
MRI, a significant difference in the enhancement of gadolinium signal compared to 
patients with normal white matter. These observations indicate that white matter 
lesions seem to be related to a disruption of the BBB. However, it should be 
emphasized that this study was performed on patients ranging in age from 69 to 83 
years old. BBB disruption has also been observed in the MCAo model, by MRI, after 
three hours of reperfusion (Sood et al., 2007).  
These data do not support the hypothesis that BBB disruption is the primary cause of 
brain damage. No published data based on the MRI methodology have examined the 
BBB permeability at earlier time points in the BCCAo model. To investigate which 
pathways may be implicated in white matter lesions (seen here after three hours of 
BCCAo) MRI studies should be extended to optimize our understanding of the 
relationships between BBB dysfunction and chronic cerebral hypoperfusion. 
Three hours after arterial occlusion, an enhancement of the signal of gadolinium was 
detected in both control and BCCAo groups and there were no differences between 
the four regions selected in each of the two groups of rats. Seven days following 
BCCAo; an enhancement of the gadolinium signal was also detected in both groups 
(sham and BCCAo) but greater in the BCCAo group than in the sham group. 
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Moreover, a significant difference of gadolinium signal enhancement between the two 
groups was detected in the external capsule and in the caudatoputamen (cf fig. 3.30). 
 
Histopathology of the enhanced microglial activation in white matter after BCCAo 
Both white and grey matter exhibited abnormal histology, revealed to be significant in 
terms of microglial activation, after seven days of BCCAo.  
Four hours post BCCAo, axonal damage and microglial activation were detected, 
while no damage to the perikarya of neurons was apparent. Seven days post BCCAo, 
perikaryal damage was detected in the BCCAo group, with axonal damage and 
microglial activation. However, despite the fact that axonal damage and ischaemic 
neuronal damage was detected in some rats, no significant differences were observed 
between the sham and BCCAo group. These data differ from the first study in that 
there were no significant differences between the sham and BCCAo groups. A 
possible explanation for this dichotomy could be the limited number of animals that 
was subjected to the MRI study (i.e. under-powered) whereas in the histopathological 
study a more important number of rats were analysed.  
White matter injury was noted after four hours of BCCAo in the histopathological 
study in the absence of any apparent damage to the perikarya. These observations 
broadly replicate those found in the initial investigation (three hours post-BCCAo) in 
which structural modifications in the white matter were manifest. The cell bodies of 
neurons in the grey matter were microscopically normal. It should be underlined that 
the time point in this second study was four and not three hours post BCCAo, because 
of practical difficulties as explained below. Microglial activation was detected in the 
MRI study (four hours post BCCAo), which was not the case after three hours 
following BCCAo in the earlier investigation. 
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Combining the results found with MRI to detect any modification in BBB 
permeability, it is reasonable to conclude that BCCAo induces in the initial phase, 
white matter injury in the absence of any alteration in BBB permeability. To 
summarize the results so far obtained: rapidly following BCCAo there is an acute 
decrease in CBF which initial causes detectable white matter lesions and this in the 
context of normal BBB permeability.  
Seven days post BCCAo, the MRI investigations revealed a significant enhancement 
of gadolinium in the white and grey matter, a finding which is translated as an 
increase of BBB permeability. This “leakiness” of the BBB coincides with the time at 
which there was a significant increase of activated microglia compared to the sham 
group found at seven days post BCCAo. Yenari and collaborators (2006) have shown 
that microglial activation radically impairs the integrity of the BBB in an in vivo 
model of experimental stroke. The mechanisms of this deleterious effect have been 
established. Microglial activation induces neuronal cell death by secreting nitric oxide 
(NO) (Chao et al., 1992). NO itself, which is a vasodilatatory agent, has been found to 
induce an increase of BBB permeability (Shukla et al., 1996). The hypothesis outlined 
above is in accordance supported by the work of Pantoni and collaborators (1996) 
who demonstrated that white matter is highly vulnerable to focal ischaemia and that a 
lethal swelling of glial cells preceded by several hours the appearance of necrotic 
neurons. This damage to the white matter leads to an activation of microglia with 
time, which could be responsible of the neuronal damage, in parallel, by the secretion 
of NO, an increase of the permeability of the BBB. 
In another rat model of chronic cerebral hypoperfusion, the expression of adhesion 
molecules of the cerebrovascular endothelial cells was induced (at one and three days) 
and lead to the infiltration of activated leukocytes into the brain parenchyma which 
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could potentially induce white matter lesions (Huang et al., 2010). However, the 
infiltration of activated leukocytes is not a pathological event but physiological, 
namely diapedesis. This enhanced microglial activation might lead with time to an 
assault to the integrity of the BBB. The article of Huang and collaborators (2010) tails 
to answer the question: “Is endothelial dysfunction of cerebral small vessel 
responsible for white matter lesions after chronic cerebral hypoperfusion in rats?”. 
These authors observed an increase in the expression of adherens molecules of the 
endothelial cells. Is this sufficient to claim a dysfunction of the endothelial cells while 
diapedesis is a physiological system of defence, and while they did not measure in this 
study the permeability of the BBB? 
Others studies demonstrated an increase of BBB permeability after chronic cerebral 
hypoperfusion in rats. Ueno and collaborators (2002) stated that it is chronic cerebral 
hypoperfusion which induces BBB permeability at one, three and seven days 
following BCCAo. They noted that they detected to a “small degree” the reaction 
product of Horseradish peroxidase using electronic microscopy after three hours of 
BCCAo. Moreover, Sood and collaborators (2008) detected an increase in BBB 
permeability after three days of BCCAo in the rat.  
The MRI in-vivo study that we implemented to detect BBB permeability appears to be 
an interesting tool for further exploration of the integrity of the BBB. 
In conclusion, this is the first study in the model of BCCAo to assess the integrity of 
the BBB at earlier time point using MRI. Moreover, it is the first study in the rat 
model of permanent BCCAo that showed an increase of Gadolinium signal 
enhancement in the caudatoputamen and in the external capsule. The results suggest 
that permanent BCCAo does not induce in itself an increase of BBB permeability, but 
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the presence of damage and activated microglia may play a role in the modulation of 
the properties of the BBB.  
Which pathways could lead to white and grey matter pathology related to BBB 
permeability? 
The last study aimed to investigate how cerebral hypoperfusion may affect levels and 
expression of proteins involved in the apoptotic and non-apoptotic pathways, to 
understand which pathways may lead to white and grey matter injury.  
 
Non-apoptotic pathway after three hours or seven days post BCCAo  
Western blot analysis of brain structures from the hemi-brain revealed no changes in 
HIF-1α, caspase-3, VEGF, MMP-2 levels compared to the sham group. On the other 
hand, RT-PCR analysis of the cortex, the corpus callosum and the caudatoputamen 
from the other hemi-brain indicated a significant expression of VEGF mRNA in the 
hypoperfused animals in those three regions compared to the sham, seven days post 
BCCAo. However, there was no difference in caspase-3 mRNA and HIF-1α mRNA 
following seven days post BCCAo compared to the sham. In a diferrent model of 
chronic cerebral hypoperfusion, by a formation of a fistula between the right external 
jugular vein and the ipsilateral common carotid artery, followed by ligation of the left 
vein of the sinus transverse and the bilateral common carotid arteries, Hai and 
collaborators (2003) demonstrated a peak of VEGF mRNA expression at seven days, 
which is consistent with our results, and also consistent with the finding of Pichiule 
and collaborators (1999) in the model of transient global ischaemia induced by 
cardiac arrest and resuscitation. In contrast to the present study, Tomimoto and 
collaborators (2003), using the same model of BCCAo we used, detected that the 
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caspase-3 mRNA was upregulated compared to the sham at one, three, seven and 30 
days post BCCAo. We have to underline that only three rats were used in Tomimoto’s 
experiment to compare the caspase-3 mRNA between the BCCAo and the sham 
animals. I have already underlined that this model of chronic cerebral hypoperfusion 
is variable between animals within the same group. To reduce this variability, it is 
important to increase the number of animals to use, to not find a result that describes 
the characteristics of one animal and not of the entire group. In our study we used 
eight animals for the BCCAo procedure compared to eight in sham, this may explains 
why we did not find a significant difference between the control and the BCCAo 
group in caspase-3 mRNA.  
MMP-2 mRNA did not appear to be changed after seven days post BCCAo in the 
study of Ihara and collaborators (2001), which supports also our finding. In contrast, 
in a severe model of focal cerebral ischaemia, in the MCAo model, Heo and 
collaborators (1999) found that MMP-2 was significantly up-regulated after one hour 
post MCAo. This can be explained by the decrease of the cerebral blood supply being 
considerable, and impairs delivery of all blood constituents such as glucose and O2, 
establishing then a hypoxic environment, and activating HIF 1-α which promotes the 
expression of MMP-2.  
When examining the results of the last study, an interesting point has to be 
highlighted.  
The apoptotic pathway does not seem to be the cause of damage to the white matter. 
Indeed, I previously described that injury occur first to the white matter, then into the 
perikarya of neurons. Moreover, the activation of the microglia is subsequent to the 
damage to the white matter tract. Then the results in this study indicate that the 
 158 
decrease of the CBF due to BCCAo is not sufficiently low to overexpress HIF-1α. But 
the injury to the white matter can be explained by the fact that it appears to be highly 
sensitive to any disturbances of the CBF in contrary to the grey matter that seems to 
be more resistant to small changes of the blood supply (Pantoni et al., 1996).   
Krick et al. (2005) showed that overexpression of HIF-1α resulted in increased 
apoptosis; which should have resulted, in our model, to a significant increase of 
Caspase-3 compare to the control group (sham). It was reported that in glioma tumor 
cells, the levels of HIF-1α increase in proportion with the level of the tumor and 
contributes to tumor proliferation through angiogenesis (Zagzag et al., 2000). HIF-1α 
gene is transcribed in the nucleus, then translated in the cytoplasm, and during 
hypoxia, it can re-enter the nucleus to form a complex with HIF-1β regulating the 
VEGF gene (Ziello et al., 2007). However, the lack of significant difference in our 
last study of HIF-1α mRNA expression between the BCCAo and the sham group, at 
seven days post surgery, remains unclear. Nevertheless, later time points in this 
BCCAo model may exhibit a significant HIF-1α mRNA expression.  
How can we understand an upregulation of HIF1-α in cerebral white matter found in 
Leukoaraiosis, being attributed to white matter hypoperfusion (Fernando et al., 
2006)? 
The work done by Fernando and collaborators in 2006 showing an upregulation of 
HIF1-α after white matter hypoperfusion cannot be compared with the rat model of 
cerebral hypoperfusion, knowing that their investigation was based on a post-mortem 
cohort of ageing human brains. Indeed the rat hypoperfusion model is not a model of 
the senescent rat; rather, BCCAo mimics the condition of hypoperfused brain seen in 
SVD but without any comorbities. Hypoperfused patients are in a longer state of 
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hypoperfusion than in the rat model. The data (Fernando et al., 2006) have shown that 
the cerebral white matter is in a hypoxic environment with a persistent expression of 
HIF1-α, which can explain the consequences of chronic and long-lasting 
hypoperfusion in ageing subjects. It is premature to say that the cause of the damage 
to the white matter is due to HIF 1-α, in that no study on the hypoperfused rat model 
has shown any time-dependent upregulation of this factor. As a hypothesis, the 
upregulation of HIF-1α observed in the hypoperfused ageing brain is the consequence 
of a chronic cerebral hypoperfusion, leading to a more severe hypoxic state. 
 
VEGF mRNA expression at seven days post BCCAo  
A novel finding of the present study is that the VEGF mRNA was significantly 
increased compared to the sham group after seven days of BCCAo. This result has not 
been previously reported in comparable models. This significant expression of VEGF 
mRNA at seven days post BCCAo could be one of the factors that lead to an increase 
of BBB permeability as found with MRI. Previous work has shown that VEGF 
negatively modifies BBB permeability in a model of focal cerebral ischaemia 
(Valable et al., 2005). In many neuropathological situations, the instability of the 
endothelial-glial interactions induces capillaries to release the VEGF which will then 
increase the permeability of the BBB (Abbott et al., 2006). In our western blot result 
for VEGF, no differences were detected between the BCCAo and sham group. The 
western blot represents the level of proteins present in the tissue, while the RT-PCR 
gives information on the expression of proteins in the tissue. These elements would 
explain that later time points should show a clearer difference between BCCAo and 
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sham group in terms of VEGF protein level as assessed by the western blot 
methodology.  
The findings detailed in this thesis supported by the scientific publications in this 
field, lead us to state that chronic cerebral hypoperfusion is a major risk for cerebral 
white and grey matter injury. To further determine the mechanisms of white and grey 
matter pathology with time in this model of SVD, an extension of studies in the 
BCCAo model is necessary. Figure 4.1 proposes a working hypothesis for the 
development of cerebral hypoperfusion leading to white matter injury a paradigm 
which could be the basis for future research projects: 
 
Fig.4.1: Proposed pathway for the development of white matter pathology. Ageing 
associated with vascular risk factors are the main causes of the development of white 
matter damage. BBB permeability may occur at a later stage which would further 
exacerbate the injury to white matter. 
 
Ageing Vascular risk factors 
Hypoperfusion 
White matter injury 
Inflammation Grey matter damage 
Blood-brain barrier permeability 
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4.1 Critics and limits of the studies 
Lack of information on BBB-related proteins 
One of the main hypotheses of this body of work was to understand if an increase of 
BBB permeability was the possible cause of white matter damage after BCCAo. 
However, we were unable to determine the level of proteins of the BBB such as tight 
junctions and adherens junctions. To complement the MRI study, it would have been 
of interest to measure the proteins levels of the tight junction (between endothelial 
brain cells) as a function of time in our model of BCCAo.  
No measurement of CBF 
Major pathological differences occurred between animals within the same group. It 
would have been interested to measure the CBF before and after the surgery, though 
the method that would ideally measure CBF is unclear. Given the dispersion of the 
lesions in neuroanatomical space and time, the solution would be to adopt multi-
modal, three-dimensional imaging to compare state-of-the-art MRI and micro-PET. 
Abnormalities detected early after BCCAo could be followed to better understand the 
evolution of white matter lesions. As stated before, there is an abundant literature on 
CBF following BCCAo in rats (see fig.2.1). Thus, global CBF measurements are of 
little interest as it varies from -50% (three days) to -25% (28 days). 
Limits tothe MRI study  
Due to practical difficulties, MRI acquisitions utilized in this study were limited and 
failed to detect any white matter changes because of the small number of animal used 
and the optimal resolution. The dispersion of the lesions has already been underlined 
with the differences between animals and group. To decrease the variability between 
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animals within a group is to increase the number of animals. Davies et al. (2005) 
noted that the rate of MTR decreases significantly in the grey matter compared to the 
white matter which corresponds to the results found in this thesis. However, no 
significant differences in MTR between the BCCAo and sham group were evidenced. 
In retrospect it is unfortunate that we did include a positive control to assure the 
certainty of identifying white matter lesions in the rat. 
Holland and collaborators (2010) showed that, with MRI, small changes of white 
matter physiology were detectable in hypoperfused mice. The effectives were 
important (Holland et al., 2010). Diffusion tensor MRI (DT-MRI) has been used to 
identify microstructural alterations in aged, compared to young brains (Pfefferbaum et 
al., 2000). Indeed, fractional anisotropy (FA), a MRI paradigm, which indicates the 
fraction of the magnitude of the diffusion tensor which can be assigned to anisotropic 
water in each voxel, was shown to be decreased even in the absence of any structural 
changes in the white matter (Harsan et al., 2008). The combination of MTR and FA in 
a large group of animals in our study would have been indicated for the detection of 
white matter changes. This was not possible in our study. The DT MRI acquisition 
lasts for two hours and the T1 acquisition to check BBB permeability to gadolinium 
lasts for one hour. The rat is fragile after three hours of maintence anaesthesia. This 







Early pathology, practical difficulties 
The T1 acquisition last for one hour, the animals of the “three hours group” were the 
perfused so that the pathology was analysed at 4 hours post BCCAo instead of three 
hours post BCCAo. The T1 acquisition was done at three hours post BCCAo. These 
technical obstacles explain, the practical difficulties incombining the two techniques 
(MRI+histology) at the earliest time points. 
The fact that no significant difference in APP immunostaining were observed at four 
hours post BCCAo, compared to the sham group, does not contradict the results of 
theinitial experiments. A significant difference was detected between the BCCAo and 
sham group from three hours to 28 days. The fact should be emphasized that the 
number of animal in the first study was greater than that in the second.  
The BCCAo rat model is not reproducible and seems to change with time and other 
factors. This variability renders reproducibility and statistical analyses difficult but 
nonetheless represents the reality of the situation in man. Patients with small vessel 
diseases do have neither the same structural damage nor the same pattern of brain 
damage presumably because of the cerebrovasculature that differs with individuals 







4.2 Future studies 
The findings described herein could be extended by future investigation of the 
mechanisms involved in the pathological alterations detailed in the thesis. Figure 4.2 
demonstrates the intimity between activated microglia with endothelial cells after 
BCCAo. Phenotypic modifications, gene expression and antigen/antibody production 
are all areas in which a research effort would be largely justified to understand the 
glial/endothelial interactions. 
Electron microscopic studies have revealed that, during experimental autoimmune 
encephalomyelitis, leukocytes cross the cerebral microvessels by a transendothelial 
process, without “opening” the endothelial tight junctions (Wolburg et al., 2005). In 
vivo two-photon microscopy (Okada, 2010) in the BCCAo model could be applied to 
the observations of the effects of chronic cerebral hypoperfusion on leukocytic 
migration through the cerebral microvessels: specifically to know the temporal 
progression of the migratory process wether this process occurs via the tight junctions 
or the endothelial cells themselves.  
As stated above, the identification of the level and expression of proteins in the tight 
and adherens junctions, at earlier and later time points, would allow a better 
understanding of the integrity of the BBB, a key component in cerebrovascular 
diseases. 
An activation of NMDA receptors in models of cerebral ischaemia leads to a state of 
ischaemic tolerance and thus confers neuroprotection (Saleh et al., 2009). The 
question arises if glutaminergic mechanisms precondition the exchange vessels of the 
brain, a question which supposes variable permeability of the BBB as a function of 
the nature and duration of the insult. Such avenues would require in vivo 
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investigations which could compare and contrast permeability in white and grey 
matter. Again, and as stated earlier, the most powerful tools available (high field MRI 
combined with micro-PET) for in vivo studies are clearly excellent to shed light on 
the temporal evolution of BCCAo-induced pathology.  
The ophthalmic and, hence its major branch, the central retinal, artery is the first and 
major intracranial branch of the internal carotid artery. Accordingly, bilateral common 
carotid artery occlusion has long been studied as a model of retinal ischaemia 
(Karpiak et al., 1989; Bacigaluppi et al., 2010 – part one; Bacigaluppi et al., 2010 – 
part two). BCCAo induces a moderate decrease in ocular blood flow which provokes, 
in sequence: the death of retinal ganglion cells (~ 1 week); neurons in the inner 
nuclear layer (~ 2 months); and, finally, the photoreceptors (~ 4 months) (Yamamoto 
et al., 2006). The early non-neuronal cell death and later loss of retinal neurons 
recapitulates some of the observations in the present thesis. 
With hindsight, it could be of considerable scientific interest to compare and contrast 
the evolution of retinal and cerebral tissues following BCCAo in the same Wistar rat. 
The same panel of antibodies would be employed to characterise the various reactive 
and degenerative changes in those two embryologically similar organs. A direct 
comparison of retinal and cerebral pathologies provoked by BCCAo could well be the 
subject of future research projects. An additional interest would be that, as with a 
blood-brain barrier, a blood-retinal barrier exists but this latter can be circumvented 
by the intra-ocular administration of pharmacological agents, antibodies or other 
barrier-limited compounds. 
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Fig.4.2: Iba-1 immunostaining counterstained with haematoxylin to indicate activated microglia (in brown) in the caudatoputamen of a rat brain 
after 14 days of BCCAo (A) and seven days post BCCAo (B). The black arrows show activated perivascular microglia while the red arrows 
show activated cells in the lumen (B). In B, activated microglia seem to be indissociable from the endothelial cells which may indicate migration 




The results from this thesis - when taken in the context of other studies in the 
literature - demonstrate that chronic cerebral hypoperfusion initiates, even at early 
times following the acute decrease in brain blood flow, a specific pathology of white 
matter which is nonetheless variable in time and space (i.e. neuroanatomical location). 
These features are reminiscent of “small vessel disease” – one of the hallmarks of 
cerebrovascular and neurodegenerative (eg dementia) disorders. 
If one accepts the postulate that, in the face of a mild but long-lasting perfusion, white 
matter pathology is the most precocious precursor of later widespread, irreversible 
neuronal loss, then the possibility for future preventative and therapeutic approaches 
is opened. At this moment in time such approaches (modulation of the functionality of 
cerebral endothelial cells, stem cell gratts in critical white matter tracts) remain both 
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Appendix A: Quantification of damage following BCCAo  
 
Quantification of ischaemic damage and presence of dark cells following chronic cerebral hypoperfusion in the rat 
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Quantification of axonal damage following chronic cerebral hypoperfusion in the rat 





Quantification of myelin débris following chronic cerebral hypoperfusion in the rat 
(approved by KH: Karen Horsburgh) 
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Appendix B: Mean grey values obtained form ImageJ after MRI acquisitions 
 


















Mean grey values obtained from T1 weighted images in ImageJ for the selected regions 
in sham and BCCAo after 3 hours of the surgery, at 0 (T1post0), 5 (T1post5), 10 










Mean grey values obtained from T1 weighted images in ImageJ for the selected regions 
in sham and BCCAo after 3 hours of the surgery, at 0 (T1post0), 5 (T1post5), 10 
























Mean grey values obtained from T1 weighted images in ImageJ for the selected regions 
in sham and BCCAo after 7 days of the surgery, at 0 (T1post0), 5 (T1post5), 10 










Mean grey values obtained from T1 weighted images in ImageJ for the selected regions 
in sham and BCCAo after 7 days of the surgery, at 0 (T1post0), 5 (T1post5), 10 





Appendix C: Tables of values of % signal enhancement of Gd-DOTA in BCCAo and sham animal 
according to the regions 
 
T1 changes of sham animals after 3 hours of surgery representing the % signal enhancement of Gd-DOTA = (Mean grey value after Gd-DOTA 
injection (T1post) – Mean grey value before Gd-DOTA injection (T1pre))* 100 / (Mean grey value before injection (T1pre)). 
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T1 changes of BCCAo animals after 3 hours of surgery representing the % signal enhancement of Gd-DOTA = (Mean grey value after Gd-DOTA injection 





T1 changes of sham animals after 7 days of surgery representing the % signal enhancement of Gd-DOTA = (Mean grey value after Gd-DOTA injection 




T1 changes of BCCAo animals after 7 days of surgery representing the % signal enhancement of Gd-DOTA = (Mean grey value after Gd-DOTA 
injection (T1post) – Mean grey value before Gd-DOTA injection (T1pre))* 100 / (Mean grey value before injection (T1pre)). 
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                               Appendix D: T2 and T1 images acquisitions with time  
 
                      SHAM                   3 Hours post BCCAo       7 days post BCCAo 
   
   
   
   
   
                                             
                                 




























        SHAM                   3 Hours post BCCAo       7 days post BCCAo 
   
   
   
   
   
   
   




























Appendix E: Full runs of Western Blots 
 
 













Levels of Caspase-3 in the Cortex (full run) 3 hours post BCCAo  
 
 


































Levels of MMP-2 in the Caudatoputamen (full run) 7 days post BCCAo 
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Levels of VEGF in the Cortex (full run) 3 hours post BCCAo 
 
 
Levels of VEGF in the Corpus Callosum (full run) 3 hours post BCCAo 
 
 
Levels of VEGF in the Cortex (full run) 7 days post BCCAo 
 208 
 















Appendix F: Publications 
Papers 
 
Holland, P. R., Bastin, M. E., Jansen, M. A., Merrifield, G. D., Coltman, R., Scott, 
F., Nowers, H., Khallout, K., Marshall, I., Wardlaw, J. M., Deary, I. J., McCulloch, 
J., Horsburgh, K. (2010). MRI is a sensitive marker of subtle white matter pathology 
in hypoperfused mice. Neurobiology of Aging. 
 
Khallout K, Jansen M.A., Merrifield G.D., Bastin M.E, Launay S., Herrmann A., 
Holland P.R., Marshall I., Horsburgh K., McCulloch J. (2012).  
Cerebral hypoperfusion causes white matter injury which precedes blood-brain barrier 





Khallout K, Jansen M.A., Merrifield G.D., Bastin M.E, Launay S., Herrmann A., 
Holland P.R., Marshall I., Horsburgh K., McCulloch J. (2011).  
Cerebral hypoperfusion causes white matter injury leading to blood-brain barrier 
dysfunction with time. International Congress of Vascular Dementia, Riga, Latvia, 
October. Received 2nd Poster Prize 
 
Holland P.R., Bastin M.E., Jansen M.A., Merrifield G.D. , Coltman R.B., Scott F., 
Khallout K., Nowers H., Marshall I., Wardlaw J. M., Deary I. J., McCulloch J. and 
Horsburgh K. (2011). Chronic cerebral hyoperfusion results in selective disruption of 
white matter; an in vivo MRI study with implications for post spreading depression 
hypoperfusion. International Headache Congress, Germany, June. 
 
Khallout K, Jansen M.A., Merrifield G.D., Bastin M.E, Launay S., Herrmann A., 
Holland P.R., Marshall I., Horsburgh K., McCulloch J. (2011). Cerebral 
hypoperfusion causes white matter injury leading to blood-brain barrier dysfunction 
with time. Neuroscience Day, Edinburgh, UK, March. 
 
Launay S, Deighton RF, Khallout K, Deary IJ, Horsburgh K, McCulloch J. (2010). 
Proteomic analysis of cell death in a rat hypoperfusion model (BCCAo). First 
Conference of the European Research Institute for Integrated Cellular Pathology 
(ERI-ICP), Institut Pasteur, Paris, France, April 
 
Bastin M, Jansen MA, Holland H, Merrifield GD, Khallout K, Horsburgh K, 
Wardlaw JM, Deary, Marshall I, McCulloch J. (2010). Quantitative tractography and 
white matter integrity in the rat brain.  
 
Launay S, Deighton RF, Khallout K, Deary IJ, Horsburgh K, McCulloch J. (2009) 
Proteomic analysis of cell death in a rat hypoperfusion model (BCCAO). Research 
into Ageing Grantholders' Conference. Birmingham, UK, September.  
2nd Poster Prize 
 
 210 
Holland, P. R., Bastin, M. E., Coltman, R., Khallout, K., Scott, F., Dingwall, T., 
Jansen, M. A., Merrifield, G. D., Marshall, I., McCulloch, J., Horsburgh, K. (2009). 
Imaging White Matter Pathology in a Mouse Model of Chronic Cerebral 
Hypoperfusion. Research into Ageing Grantholders' Conference. Birmingham, UK, 
September. 
 
 
 
 
 
 
